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Abstract 
 
The interaction of propofol and L-arginine with β-amyloid (1-40) (Aβ) have been investigated 
by using UV-absorption spectroscopy, fluorescence spectroscopy, Fourier transform infrared 
(FTIR) spectroscopy, and atomic force microscopy (AFM). The binding constants have been 
determined by both UV-absorption spectroscopy and fluorescence spectroscopy. The values of 
the binding constants calculated at 293K are (2.13x102M-1, 2.81x102M-1) for propofol, and 
(0.35x102M-1, 0.37x102 M-1) for L-arginine. The Stern-Volmer quenching constant values 
were found to be 1.21x103L.mol-1 for propofol and 1.49x103L.mol-1 for L-arginine.  
The fluorescence data reveals a decrease in Aβ-drug emission intensity with the increase of 
propofol and L-arginine concentration. This decrease in intensity indicates that both propofol 
and arginine have strong ability to quench the intrinsic fluorescence of Aβ through static 
quenching mechanism. 
All peak positions in the amide I and amide II regions have been assigned, and any effect due 
to concentration changes have been investigated. The FTIR spectra measurements indicate a 
change in the intensity of the absorption bands due to the change in ligand concentration. An 
increase in the intensity of anti-parallel β-sheet bands with increasing propofol concentration 
has been observed. This increase is associated with the formation of oligomers or fibrils in the 
Aβ. On the other hand a decrease in the intensity of anti-parallel β-sheet band with increasing 
L-arginine concentration has been observed. It has been found that L-arginine decreased the 
rate of oligomerization and amyloid fibrils formation. 
It has been found that changing temperature have no effect on the intensity of the absorption 
bands of parallel and anti parallel β-sheet in Aβ free. For Aβ-propofol complex the intensity of 
anti-parallel β-sheet band has increased gradually with increasing temperature, this increase in 
the intensity of anti-parallel β-sheet band is accompanied with a decrease in parallel β-sheet 
band intensity. For Aβ-L-arginine complex the intensity of anti parallel β-sheet band has 
decreased accompanied with an increase in parallel β-sheet band intensity until the 
temperature is 330C, then the intensity of anti-parallel β-sheet band starts to increase and that 
of parallel β-sheet starts to decrease gradually. 
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AFM images were also taken for Aβ-free, Aβ-propofol complex, and Aβ-L-arginine complex 
to compare the effect of these ligands on Aβ and verify our results. AFM images showed an 
increase in the size of oligomers after propofol addition to Aβ.  
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 Introduction 
 
This research is concerned with using spectroscopic techniques such as Fourier Transform 
Infrared Spectroscopy (FTIR), UV-Vis spectroscopy, Fluorescence spectroscopy, in addition 
to Atomic Force Microscopy (AFM) to investigate the effect of propofol, and L-arginine on 
Beta-Amyloid (Aβ) (1-40). Aβ is a peptide that is secreted from neurons under normal 
conditions after cleavage of amyloid precursor protein (APP). Aβ is considered as one of the 
byproducts of APP processing (Jimenez 2005). Several studies have been performed using 
several spectroscopic techniques and discovered that Aβ protein is one of the major 
components of amyloid plaques, which are deposits that are found in the brains of the patients 
with Alzheimer disease (AD) (Takahashi et al 2002, Lin 2003, El-Agnaf et al 2000). 
AD is characterized by loss of memory and language skills. Studies on Aβ have been done and 
it has shown that due to the toxicity of Aβ, fibrillar Aβ can directly kill the neurons or initiate 
a series of events leading to a neuronal cell death (Walsh et al 1999, Fodale et al 2006). 
Many researches have been done throughout the world to develop compounds that interfere 
with amyloid aggregation. It has been found that amyloid oligomers and fibrils were 
characterized by β-sheet secondary structural arrangement (Murphy 2002, kirkitadze et al 
2001, Lindgren& Hammarstrom 2010). This research examines the effect of L-arginine and 
propofol in forming oligomers in Aβ.  
Propofol is a fast effective anesthetic drug that is widely used in surgery throughout world 
(Aschenbrenner & Venable 2009, Silverstein et al 2008). L-arginine is a complex amino acid 
found in proteins and enzymes, kidneys produce about 60% of L-arginine in human body, and 
it may be synthesized in the liver. The best diet sources of L-arginine are meat, peanuts, 
soybeans and eggs (Stayton et al 2008, Stargrove 2008). 
The first spectroscopic technique that is used in the process is FTIR which is used in order to 
investigate the conformational changes on the secondary structure of Aβ upon the addition of 
different concentrations of propofol and L-arginine on it. Investigation of structural changes 
includes changes in peak positions and changes in the relative intensities of the secondary 
structural elements are performed. Also the effect of temperature on Aβ-free, Aβ-propofol 
complex, and Aβ-L-arginine complex are examined. 
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UV-absorption spectroscopy is the second spectroscopic technique that is used to investigate 
the strength of interaction between Aβ with propofol and L-arginine. The binding constant 
between the ligands and Aβ will be determined.  
Fluorescence spectroscopy was used to confirm the calculation of binding constants as an 
indication of the strength of interaction. The Stern-Volmer quenching constants for propofol 
and L-arginine interaction with Aβ will also be calculated. 
AFM images of Aβ free, Aβ-propofol complex, and Aβ-L-arginine complex will be taken. 
These images are used to investigate changes of the sizes of upon addition of propofol or L-
arginine to Aβ. 
The first chapter is an introduction. It shows the purpose and the importance of this work. It 
also gives information about each chapter in this thesis. 
In the second chapter of this thesis the physical background and theoretical considerations of 
the spectroscopic will be discussed, then a brief introduction to spectroscopic technique used 
in this research will be given. A brief introduction to proteins, their structural levels, and 
protein misfolding are given, also AD will be introduced, then information about materials 
used (Propofol, L-arginine, and Aβ) are given. 
In chapter three the experimental part of the study is discussed in details. Sample preparation 
from the moment of taking the solid protein sample to the moment of inserting the sample 
inside FTIR equipment is explained. A brief discussion of the instruments is given, and then 
the experimental procedure followed in taking the needed data is mentioned. 
In chapter four results are analyzed and discussed. The UV-absorption spectroscopy results are 
plotted and used to calculate the binding constant between Aβ and both propofol and L-
arginine. The absorption spectra of Aβ with different concentrations of propofol and L-
arginine are shown. 
A plot of the fluorescence emission spectra of Aβ in the absence and presence of propofol and 
L-arginine are shown. The binding constant, Stern-Volmer quenching constants and the 
quenching rate constant of the bio-molecule will be calculated.  
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FTIR has been used to investigate the conformational changes in Aβ after binding to propofol 
or L-arginine. Changes in amide I and e II peaks positions for Aβ with different concentrations 
of propofol and L-arginine are investigated, also changes in the intensity of the component 
bands of the secondary structure as a result of changing concentrations of propofol and L-
arginine have been shown. The effect of changing temperature on the peak positions and on 
the intensity of β-sheet bands for Aβ free, Aβ-propofol complex, and Aβ-L-arginine complex 
have been examined. 
AFM images for Aβ in the absence and presence of propofol and L-arginine are shown. 
Comparison between the three images will assist in distinguishing the effect of each ligand on 
Aβ. 
The last chapter contains the conclusion and it also recommends future work that can be done 
in this field. 
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Chapter two: 
 
Background and Theoretical Consideration 
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This chapter discusses spectroscopy in general and explains the physical principles of the 
spectroscopic techniques that have been used in the work. A brief introduction to proteins and 
Alzheimer disease, Aβ, propofol, and L-arginine is given. 
2.1 ELECTROMAGNETIC RADIATION 
  
Electromagnetic waves (EMW) are transverse oscillating waves composed of electric and 
magnetic fields perpendicular to each other and perpendicular to the direction of propagation. 
EMW propagate as a sine or cosine waves at the speed of light in vacuum (Stuart  2004). 
The electromagnetic spectrum consists of radio waves, microwaves, infrared radiation, visible 
light, ultraviolet radiation, X-rays and gamma rays as show in (Figure 2.1).  
 
Figure 2.1: The electromagnetic spectrum (Sharma 2007, Ball 2001). 
Wavelength (λ) is inversely proportional to frequency(ν) and it is governed by the relation: 
ߣ ൌ ௖
ఔ
                                      (1)  
Where c is speed of light and ν is the frequency. 
Electromagnetic radiation is composed of multiple electromagnetic waves or photons, which 
carry energy, momentum and angular momentum. 
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The energy of each photon is given by Planck–Einstein equation:  
ܧ ൌ ݄ߥ ൌ ݄ ௖
ఒ
 ----------------------------               (2) 
Where E is the energy, h is Planck's constant,  ߥ is frequency, and ߣ is wavelength (Pavis et al 
2008, Yadav 2005, Williams 1976, Ball 2001). 
The atomic spectra arise from the transition of electron between atomic energy levels, while 
molecular spectra arise from three types of energy transitions due to molecular rotation, 
molecular vibrational, and electronic transition. According to Born Oppenheimer 
approximation, the total energy of the molecule is given by :  
ܧ௧௢௧௔௟ ൌ ܧ௥௢௧ ൅ ܧ௩௜௕ ൅ ܧ௘௟ ൅ ڮ  --------------------           (3) 
Where: ܧ௥௢௧:  is rotational energy due to the molecule rotation about the axis passing the 
center of gravity for the molecule. 
ܧ௩௜௕:  is vibrational energy due to the periodic displacement of atoms around their equilibrium 
positions  
  ܧ௘௟ : is related to the energy of the molecule's electrons (Sharma 2007). 
When radiation falls on a sample it may be absorbed, this occur when the energy of radiation 
matches the difference in energy levels of the sample, otherwise it may be either transmitted or 
scattered by the sample. A simplified representation of the quantized electronic and vibrational 
states is represented in (Fig 2.2). It is clear that transitions between electronic energy states 
require more energy than transitions between vibrational energy states (Hollas 2004, Turro 
1991, Ball 2001). 
 
IR radiation does not have enough energy to induce electronic transitions as seen with UV and 
visible light. Absorption of IR is appropriate to excite vibrational and rotational states of a 
molecule as shown in (Fig 2.1) 
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Figure 2.2: A schematic representation of the quantized electronic and vibrational energy 
levels of a molecule. 
 
Intensity of the light absorbed to produce a given transition is given by Beer-Lambert law: 
ூ
ூబ
ൌ 10ିఌ௖௟---------------------                     (4) 
In which ܫ and ܫ଴ are the intensity of light transmitted through the absorber and incident upon 
it respectively.  ε:  is the molar absorption coefficient or (molar extinction coefficient), c: is 
the concentration of absorbing molecule in the sample, and ݈: is the length of the light path in 
the sample. The above equation can be represented in logarithmic form: 
 ܣ ൌ logଵ଴
ூ೚
ூ
ൌ ߝሺ߭ሻ݈ܿ ------------------          (5) 
Where A is called Absorbance (Hollas 2004, Schulman 1977). A setup for an absorption 
instrument is shown in (Fig 2.3). 
 
Figure 2.3: A setup of an absorption measurement 
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2.2 MOLECULAR VIBRATIONS 
 
When the temperature is above absolute zero all atoms in the molecule undergoes vibrational 
motion with respect to each other, if the incident radiation has energy that matches the 
difference in energy between vibrational levels of atoms in the molecules, the molecule will 
absorb energy and become excited. 
 
There are two types of molecular vibrations, stretching (change in bonds length) and bending 
(change in bonds angel). The bond can stretch in phase (symmetrical stretching) or out of 
phase (asymmetric stretching) (Stuart 2004, Griffith & Haseth 2007, Williams 1976). 
 
A polyatomic molecule with N atoms has a total of (3N) degrees of freedom; three of which 
are translational, and three rotational for nonlinear molecules, while two rotational degrees of 
freedom for linear molecules. The remaining degrees of freedom are for vibrational motion. 
They are 3N-6 for nonlinear molecules and 3N-5 for linear molecules, as shown in (Table 2.1) 
(Stuart 2004). 
 
Table 2.1: Molecule degrees of freedom. (Stuart, 2004) 
 
 
Not all of these fundamental vibrations are IR active, only those produce a net change in 
dipole moment will give an IR-absorption spectrum.  
10 
 
Each mode of vibration involves harmonic displacement of the atom from their equilibrium 
position, for any mode ( i ), the atom vibrates with frequency (νi) , the potential energy V(r) for 
harmonic oscillator is shown by the dashed line in (Fig. 2.4) as a function of the distance 
between the atoms (r). For any mode in which the atoms vibrate with simple harmonic motion, 
the vibrational energy states can be described by:  
௜ܸ ൌ ݄ߥ௜ ቀ݊௜ ൅
ଵ
ଶ
ቁ----------------------- (6) 
Where ݄: Plank’s constant, ߥ௜: fundamental frequency for a particular mode, ݊௜: vibrational 
quantum number for the ith mode (n= 0, 1,2,…). Note here that the frequency ߥ௜ is measured in 
Hertz (Griffith & Haseth 2007). 
 
 
 
Figure 2.4: Potential energy for a diatomic molecule as a function of atomic displacement 
during vibration for a harmonic oscillator (dashed line) and anharmonic oscillator (solid line). 
The actual vibration of the potential energy as a function of displacement is given by (Fig 2.4 
solid line). It is clear that (equation 6) is valid only at low values of vibrational quantum 
number and is not valid when ݊௜ is large. In practice the potential energy must be described by 
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the model of anharmonic oscillator (Morse-type potential function). To a first approximation it 
is given by the following equation: 
௜ܸ ൌ ݄ߥ௜ ቀ݊௜ ൅
ଵ
ଶ
ቁ ൅ ݄ߥ௜ݔ௜ሺ݊௜ ൅
ଵ
ଶ
ሻଶ   ----------(7) 
Where ݔ௜: is the anharmonicity constant that is dimensionless and has typical values between 
0.001-0.02 depending on the mode of vibration (sathyanariana 1983). 
For many vibrational modes a large number of atoms in the molecule are almost stationary and 
only few of them have large displacements. The frequency of such mode is characteristic of 
the functional group of these molecules and it is almost unaffected by other atoms in the 
molecule, which enabled scientist to assign each absorption band in the infrared region to a 
typical functional group (Griffith & Haseth 2007). The assigned wave number for each 
function group is shown in (Table 2.2). 
 
Table 2.2: Typical bond stretching and angel-bending group vibrations (Hollas 2004). 
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2.3 SPECTROSCOPY 
 
 
Spectroscopy is experimental techniques deal with absorption, emission, or scattering of 
electromagnetic radiation by atoms or molecules, it deals with interaction between EM 
radiation and matter (Michael Hollas, 2004). 
An incident photon that can induce transition between rotational levels of a molecule is found 
in the microwave region, while the transition between vibrational levels is induced by a 
photon in the infrared region, electronic transitions in atoms or molecules give radiation in the 
visible and UV (Ultraviolet) region (Sharma 2007). 
 
2.3.1.  Infrared spectroscopy: 
 
 
Infrared spectroscopy is a technique based on the absorption of infrared radiation by 
molecules, when molecules absorb infrared radiation they will be excited to a higher 
vibrational energy states. This absorption of infrared radiation process is quantized as a 
molecule absorbs only selected frequencies of infrared radiation (Pavis et al 2008). 
Sometimes radiation have a frequency that matches the natural vibrational frequencies of the 
bonds in the molecule but the bonds are not capable of absorbing it, the reason is that for 
bonds to be capable of absorbing infrared radiation it must possess a dipole moment that 
changes as a function of time at the same frequency as the incoming radiation, an example of 
infrared inactive molecule is homo-nuclear diatomic molecule because it’s dipole moment 
remain zero ( Stuart 2004, Raaman 2006). 
 
Infrared radiation is an electromagnetic radiation lies between visible light and microwave 
region. It is divided into three sub regions, near, far, and mid infrared region. 
 
Near infrared region is assumed to lie between ( 0.78 - 3µm) or (12820 – 4000 ܿ݉ିଵ), mid 
infrared region lies between (3-30 µm) or (4000-400 ܿ݉ିଵ), and far infrared region between 
(30-300 µm) or (400 - 33ܿ݉ିଵ) (Griffith & Haseth 2007). 
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The presence of hydrogen bonding is of great importance in infrared spectroscopy, it is 
defined as the attraction that occurs between a highly electronegative atom carrying a non-
bonded electron pair (such as fluorine, oxygen or nitrogen) and a hydrogen atom, itself bonded 
to a small highly electronegative atom as shown in (Fig 2.5). 
 
Figure 2.5: Intramolecular hydrogen bonding in a protein (dashed line). 
The hydrogen bonding influences the bond stiffness and so alters the frequency of vibration. 
For example, for a hydrogen bond in an alcohol, the O–H stretching vibration in a hydrogen-
bonded dimer is observed in the 3500–2500 cm−1 range, rather than in the usual 3700–3600 
cm−1 range (Stuart 2004, Griffith & Haseth 2007). 
 
 
Figure 2.6: Effect of hydrogen bonding on an O–H stretching vibration (Stuart 2004). 
 
2.3.2. Fourier transforms infrared spectroscopy (FTIR): 
 
When a sample is exposed to infrared radiation some of this radiation will be absorbed and 
some will pass through the sample (transmitted). The resulting spectrum shows the molecular 
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absorption or transmission and creates a molecular fingerprint of the sample as shown in (Fig 
2.7). No two molecular structures produce the same spectrum, and this make FTIR useful in 
studying several types of molecules. 
 
 
Figure 2.7: Incident and transmitted IR-radiation upon passing through a sample. 
Organic molecules can absorb IR radiation between 4000 cm
-1 
and 400 cm
-1 
which 
corresponds to absorption of energy between 1.24meV-1.7eV. This amount of energy initiates 
transitions between vibrational states of bonds contained within the molecule (Buxbaum 
2011). 
Transitions between vibrational energy levels follow the same equation as for a classical 
harmonic oscillator: 
ߥ෤ ൌ ଵ
ଶగ௖ ට
௞
ఓ
  --------------------------------- (8) 
Where ߥ෤: is wave number in cm-1 
             ݇: is the force constant. 
              ߤ: is the reduced mass of the system, which is given by: 
ߤ ൌ ௠భ௠మ
௠భା௠మ
  ------------------------ (9) 
From the above equations it can be noticed that as the value of force constant (k) increases the 
vibrational frequency and so the energy will increase, and energy will decrease when the 
masses increase.  
 
The design of optical pathway produce a pattern called interferogram. 
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FTIR uses an interferometer to process the energy that passes through the sample. In the 
interferometer the infrared source energy passes through a beam splitter; a mirror placed at 
angel 45଴ to the incoming radiation; that divides the beam into two perpendicular beams. As 
shown in the schematic diagram in (Fig.2.8). The deflected beam goes to a fixed mirror and is 
then returned to the beam splitter. The un-deflected light beam goes to a movable mirror and 
return back to the beam splitter, the path length of the second beam varies as a result of mirror 
motion. The two beams then recombine when they meet at the beam splitter forming a 
destructive or constructive interference as a result of path length difference between the two 
beams, and so the merged beams will cover a wide range of wavelengths.   
For a single IR frequency, when the two arms of the interferometer are of equal length, the 
two split beams travel through the exact same path length and are totally in phase with each 
other, thus they interfere constructively and lead to a maximum in the detector response. This 
position of the moving mirror is called the point of zero path difference (ZPD). When the 
moving mirror travels in either direction by the distance (λ/4), the optical path (beamsplitter–
mirror–beamsplitter) is changed by 2 (λ/4), or (λ/2). The two beams are 180° out of phase with 
each other, and thus interfere destructively. As the moving mirror travels another (λ/4), the 
optical path difference is now 2 (λ/2), or (λ). The two beams are again in phase with each 
other and result in another constructive interference. 
When the mirror is moved at a constant velocity, the intensity of radiation reaching the 
detector varies in a sinusoidal manner to produce the interferogram output, the interferogram 
is a record of the interference signal, and it is a time domain spectrum (a plot of intensity of 
radiation versus time). Then a mathematical operation “Fourier Transform” will convert the 
interferogram to the final IR spectrum which is a frequency domain that is a plot of intensity 
versus frequency (Aruldhas 2007, Griffith & haseth 2007, Raaman 2006). 
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Figure 2.8: Michelson interferometer. 
The Fourier transform pairs are mathematical relations used in transformation from time 
domain spectrum (the changes in the radiant power ݂ሺݐሻ  is recorded as a function of  ݐ ) into 
frequency domain spectrum (which records the radiant power ܩሺ߱ሻ ܽݏ a function of  ߱) and 
vice versa, these two equations are:  
ܩሺ߱ሻ ൌ ଵ
√ଶగ
׬ ݂ሺݐሻ݁௜ఠ௧݀ݐஶିஶ   ------------------------- (10) 
݂ሺݐሻ ൌ ଵ
√ଶగ
׬ ܩሺ߱ሻ݁ି௜ఠ௧݀߱ஶିஶ    ------------------------- (11) 
Where ߱ is the natural angular frequency (Barbara Stuart 2004, G. Aruldhas 2007).  
The transformed interferogram is then oriented toward the sample, the sample absorbs all the 
frequencies that match its natural vibrations. The remaining spectrum then reaches the detector 
(Pavis et al 2008, Smith 2011). The layout and components of FTIR are shown in (Fig 2.11). 
 
Figure 2.9: the layout and the main components of FTIR. 
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Amide bands: 
There are nine infrared absorption bands for a polypeptide or a protein which are: amide A, B, 
and I-VII. The amide I and II bands are the two most prominent vibrational bands of the 
protein backbone. The most sensitive spectral region for the protein secondary structure is the 
amide I band (1700-1600 cm-1), which is due almost entirely to the C=O stretching vibrations. 
The amide II is mainly from the in-plane NH bending vibration and from CN stretching 
vibrations. Other amide vibrational bands are very complex depending on the details of the 
force field, the nature of side chains, and hydrogen bonding. So it is rarely used in the studying 
of protein structure. All characteristic amide bands are shown in (Table 2.3) (Kong & Yu 
2007, Smith 2011, Raaman 2006 ). 
 
Table 2.3: Characteristic amide bands of peptide linkage (Kong &Yu 2007, Smith 2011). 
 
 
In amide I region (1700-1600 cm-1), molecular geometry and hydrogen bonding pattern will 
give rise to different C=O stretching vibration. The amide I band contour consists of 
overlapping component bands (α-helix, parallel β-pleated sheet, anti parallel β-pleated sheet, 
random coils, and β-turns).characteristic software is used to assign each component band 
(Kong &Yu 2007). 
Deuterium oxide (D2O) is employed in infrared studies more than water (H2O) since water 
absorbs strongly in the spectral region that overlap with amide I band and therefore it can 
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affect the spectra, on the other hand D2O has relatively low absorbance in the region between 
1400-1800 cm-1(Bai & Nussinov 2007). 
Some proteins frequencies and the assigned secondary structural element in amide I band 
when employing H2O or D2O are shown in (Table 2.4) 
 
Table 2.4: Deconvoluted amide I band frequencies and assignments to secondary structure for 
protein in D2O and H2O media (Kong &Yu 2007). 
 
 
2.3.3. Ultraviolet-Visible Spectroscopy (UV-vis): 
 
UV-Vis spectrum results from interaction between electromagnetic radiation in the UV-Vis 
region and molecules, the absorption of radiation in this region depends on the electronic 
structure of the absorbing species, when the incident photon energy matches the difference in 
the energy of these electronic levels (Sharma 2007). 
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To obtain UV-Vis Spectrum the sample is irradiated with electromagnetic radiation varied 
over a range of wavelengths in the UV or visible regions. A monochromatic radiation is 
employed at a time; the intensity of radiation absorbed at each wavelength is plotted against 
wavelength to obtain the spectrum. 
 
The characteristics of UV-Vis spectrum depend on the structure and concentration of the 
absorbing species in solution (Kalsi 2004). 
 
The wavelength of the radiation that will be absorbed by organic molecule is determined by 
the difference in energy between ground state and the various excited electronic states of the 
molecule. Atoms in organic molecules are bonded through σ and π bonds, and the possible 
transitions between them is shown in (Fig. 2.10), as a rule the transition occur from HOMO 
(Highest Occupied Molecular Orbital) to LUMO (Lowest Unoccupied Molecular Orbital). Of 
all the six transitions shown in (Fig 2.10), only the two of lowest energy (݊ ՜ ߨכ ܽ݊݀ ߨ ՜
ߨכ) can be achieved with radiation available in the range 200-650 nm which corresponds to 
UV-vis region (Yadav 2005, Kalsi, 2004, Raaman 2006). 
 
 
Figure 2.10: Generalized molecular orbital energy level diagram and possible transitions for 
organic compounds (Yadav 2005, Raaman 2006). 
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 The ߨ ՜ ߨכ transitions are generally intense while ݊ ՜ ߨכ transitions are weak, so only 
molecules that have π bonds and atoms with non bonding electrons absorb light in the range 
200-700nm and it is called chromophores. A list of some chromopheric bonds and their 
absorption characteristics are given in (Table 2.5), and absorption ranges for various electronic 
transitions are shown in (Fig 2.11) (Kalsi, 2004). 
 
 
Figure 2.11: Absorption ranges for various electronic transitions. 
Table 2.5: Absorption characteristics of some common chromophoric groups (Kalsi, 2004). 
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2.3.4. Fluorescence: 
 
Luminescence is the emission of light from atoms when it is electronically exited. It is divided 
into two categories fluorescence and phosphorescence. 
 
Fluorescence: 
At room temperature most of the electrons occupy the lowest vibrational level of the ground 
electronic state (S0) , and when they absorb light they produce exited states, the transitions to 
the first and the second excited  states (S1, S2 respectively) are shown in (Fig. 2.12) 
(Schulman, 1977). 
 When a molecule absorbs energy, it reaches a higher vibrational level of the excited state, if it 
maintains its spin, it is a singlet state (S) while if its spin i changed it is a triplet state (T),  the 
excited molecule then rapidly loses its excess of vibrational energy and falls to the lowest 
vibrational level of the excited state. Returning from singlet state to the ground state is fast 
while returning from triplet state requires spin reversal and so is slower and less likely to 
occur. As shown in (Fig. 2.12) there are sub states associated with each singlet or triplet states 
they are caused by vibration and rotation of the molecule. If the energy of the sub-states of the 
ground state and those of the excited state overlap, direct return of the electron to the ground 
state is possible by internal conversion, the energy difference is converted to molecular 
vibration, that is, heat. 
If the energy of the sub-states of the ground state and those of the excited state do not overlap, 
then direct returning to the ground state is impossible, instead the electron first falls to S1 via 
internal conversion, and from there it returns to S0 by emission of light as shown in (Fig. 
2.12), the energy difference between S2 and S1 is lost as molecular vibration (heat), and thus 
the light emitted will have less energy and so longer wave length than that absorbed this 
phenomena is called fluorescence (Lakowicz 2002, Sharma  2007, Buxbaum 2011). 
Fluorescence usually occurs from fluorescent substances such as aromatic molecules called 
fluorophores. Fluorophores are divided into two main classes: intrinsic fluorophores which 
occur naturally such as amino acids (aromatic amino acids Tryptophan, tyrosine, and 
phenylalanine), and extrinsic fluorophores which are added to the sample to provide 
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fluorescence when it does not exist or to change the spectral properties of the sample 
(Lakowicz 2006). 
 
Phosphorescence:  
Upon production of excited states by promotion of an electron into a higher orbital the 
direction of spin of the electrons is preserved, since most of molecules have an even number 
of electrons they will be arranged in pairs. However, it is possible for the spin of the promoted 
electron to be reversed so that it is no longer paired and the molecule has two independent 
electrons of the same spin in different orbitals. Quantum theory predicts that such a molecule 
can exist in three forms that differs slightly, but normally indistinguishable in their energy, and 
the molecule is said to exist in a triplet state. The indirect process of conversion from the 
excited state which is produced by absorption energy from singlet state to a triplet state is 
known as intersystem crossing (Fig. 2.12) and can occur in many substances when the lowest 
vibrational level of the excited singlet state, S1, has the same energy level as an upper 
vibrational level of the triplet state (Sheehan 2009). 
Direct transition from the ground state, usually singlet state, for a molecule with an even 
number of electrons, to an excited triplet state is theoretically forbidden, which means that the 
reverse transition from triplet to ground state will be difficult. Thus, while the transition from 
an excited singlet state, for example, S1, to the ground state with the emission of fluorescence 
can take place easily and within 10-9 –10-6 seconds, the transition from an excited triplet state 
to the ground state with the emission of phosphorescence requires at least 10-4 seconds and 
may take as long as 102 seconds, so phosphorescence can be defined as the transitions from 
the triplet state to the ground state (Sharma 2007, Lakowicz 2006). 
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Figure 2.12: one form of Jablonski diagram shows how fluorescence and phosphorescence 
occur (Lakowicz 2006). 
 
2.3.5. Quenching: 
 
Decrease of fluorescence intensity by interaction of the excited state of the fluorophores with 
its surroundings is known as quenching and is relatively rare. Quenching can occur in several 
mechanisms, collisional quenching occurs when exited state fluorophores are deactivated upon 
contact with some other molecule in solution, which is called quencher (Sheehan 2009). For 
collisional quenching the decrease in intensity is given by Stern-Volmer equation: 
ܨ଴
ܨ ൌ 1 ൅ ܭ
ሾ݈ሿ ൌ 1 ൅ ݇௤߬଴ሾ݈ሿ 
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Where ܭ is Stern-Volmer quenching constant, ݇௤ is biomolecular quenching constant, ߬଴ is 
the unquenched lifetime, and ݈ is the quencher concentration. The quenching constant ܭ 
indicates the sensitivity of the fluorophores to the quencher. There are a wide variety of 
molecules that acts as a collisional quencher such as oxygen, halogen, amines, and electron-
deficient molecules like acrylamide. Quenching mechanism differ according to fluorophores 
quencher pair, for instance quenching of indole by acrylamide occur as a result of electron 
transfer from indole to acrylamide, while quenching by halogens and heavy atoms occurs as a 
result of spin orbit coupling and intersystem crossing to the triplet state ( Lakowicz, 2006, 
Sheehan 2009). 
Static quenching is another type of quenching. It occur in the ground state and does not rely on 
diffusion or molecular collisions. It occurs as a result of complex formation in the ground state 
between fluorophores and quencher (Turro, 1991). 
 
2.3.6. Atomic force microscopy (AFM): 
 
AFM is a high resolution type of scanning probe microscopy; its resolution is in the order of 
fractions of nanometer. It can examine rigid surfaces either in air or in liquid (Braga & Ricci 
2004). 
AFM consists of a cantilever with a sharp tip used to scan the specimen surface; the tip is 
made of silicon or silicon nitride. It has a radius of curvature in the order of (10-20) 
nanometers. Forces between the sample and tip cause deflection in cantilever. This deflection 
can be measured using a laser spot reflected from the top surface of the cantilever, as any 
deflection in the cantilever will change the position of the laser spot on the photodetector that 
consists of two side by side photodiodes ( Samori 2008, Bowen & Hilal 2009). 
The amount of force between the probe and the sample is dependent on the spring constant of 
the cantilever and the distance between the probe and the sample surface. This force can be 
described by Hook’s law: 
ܨ ൌ െ݇ݔ 
Where k: is the spring constant and x: is the cantilever deflection (Wilson & Bullen). 
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2.4  PROTEINS 
 
In this work we investigate proteins. Proteins are polymers composed of 20 different amino 
acids joined by peptide bonds. The structure of an amino acid contains an amino group, a 
carboxyl group, and R-group which is usually carbon based and gives the amino acid its 
specific properties. The basic structure of amino acid is shown in (Fig 2.13).  
 
Figure 2.13: Basic amino acid structure. 
Peptide bond is that bond between amino group of one amino acid and carboxyl group of the 
other. As a result of this reaction dipeptide is formed and a water molecule is eliminated. 
Peptide bond is responsible for the main chain or backbone of poly peptide chain. As an 
example the peptide bond between Glycine and Alanine is shown in (Fig. 2.14) (Whitford 
2005). 
Proteins are found in every living organism, they are responsible for a wide variety of 
functions, and proteins accomplish their tasks in the body by three-dimensional tertiary and 
quaternary interactions between various substrates 
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Figure 2.14: the peptide bond between Glycine and Alanine to form Glycylalanine. The 
peptide bond is shown on red and arrow assign to it. 
 
2.4.1. Structural levels of protein: 
 
There are four levels of protein structure, the primary structure which is determined by the 
linear sequence of amino acids in poly peptide, secondary structure can take the form of either 
α-helix or β-strands which is formed as a result of hydrogen interaction between N-H and C=O 
group in the invariant parts of amino acids in the poly peptide backbone. Elements of either α-
helix, or β-sheets, or both, or loops, and unstructured elements are folded into a tertiary. A 
number of Tertiary structured polypeptides associate to constitute the Quaternary structure of 
protein. These structural levels are shown in Fig. 2.15 (Petsko & Ringe 2004). 
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Figure 2.15: structural levels of protein. 
2.4.2. Protein structural forms: 
 
The secondary structure of a protein includes four particularly structural forms. α-helix which 
is formed when the amino acid backbone curls around. Alpha helix is stabilized by hydrogen 
bonds between the carbonyl oxygen of one amino acid and the backbone nitrogen of a second 
amino acid located four positions away. β-sheets consist of beta strands connected by at least 
two or three backbone hydrogen bonds, forming a generally twisted, pleated sheet. β-sheets 
have two categories, parallel, in which all carboxyl terminal end are at the same side, or anti-
parallel. The other elements of secondary structure include β-turns, random coils, and 
unordered structure. β-turns are sharp turns that connect the adjacent strands in an anti-parallel 
β-sheet. Unordered structures are loops that form near the surface of protein and join other 
elements of secondary structure. Alpha helix and beta-sheets are shown in (Fig. 2.16) below 
(Fasman 1990, Petsko & Ringe 2004, Buxbaum 2007). 
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Figure 2.16: α-helix (left handed), β-sheets (right handed). 
 
Figure 2.16: Representation of alpha helix, parallel beta sheets, and anti parallel beta sheets. 
 
2.4.3. Protein misfolding: 
 
Protein misfolding (or protein conformational ) diseases occur when protein fail to adopt or 
remain in its functional form, the larger group of misfolding diseases are related to a specific 
peptide called Amyloid, in a process called Amyloidosis (Chiti 2006). 
Amyloidosis is any pathological state associated with the formation of extracellular amyloid 
deposits of insoluble fibrils or plaques, which form when the normally soluble amyloid 
misfold and self associate in abnormal matter (Lindgren & Hammarstrom 2010). There are 
over 20 diseases related to Amyloidosis such as AD, Parkinson’s, diabetes type II, Huntington 
disease, and the prion diseases. Each one of these diseases is associated with a deposition of a 
poly peptide that aggregates and accumulates in the tissue in an irreversible manner to form 
amyloid fibrils or plaques in a specific body organ (Robin et al 2010). Until now there is no 
effective treatment for any of the cardiovascular, systemic, or neurodegenerative amyloidosis, 
including AD (Wang, 2008). 
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2.5 Alzheimer disease (AD) 
 
Alzheimer disease (AD), was first described by Alois Alzheimer in 1906, as a progressive 
neurodegenerative disorder disease characterized by multiple pathological changes in the 
brain, leading to memory loss (Juszczyk  2009). AD is the most known cause of dementia 
worldwide (Kirkitadze et al 2001). In the united states alone it affects about 4.5 million 
people, and the number is expected to exceed 13 million by the year 2050 (Stein et al. 2004, 
Collins & Dawes 2007). It affects more than 27 million people worldwide (Lee 2010). 5% of 
people over the age of 65 and 20% of people over the age of 80 are affected with Alzheimer 
disease (Collins & Dawes 2007). AD is characterized by β-amyloid aggregation and plaque 
formation (Walsh et al 1999, lee & Chapman 2010). 
 
Recent reports have suggested that AD might be accelerated by aesthesia and surgeries at old 
and earlier ages (Carnini 2007, Bohnen 1994). A study by California Alzheimer Disease 
Diagnostic and Treatment Centre Program examined the different risk factors related to AD; 
they discovered that general anesthesia is a risk factor for AD (V. Fodale et al. 2010, 
Eckenhoff et al. 2004). 
 
Hence, it is important to understand the effect of anesthetic drugs on the proteins related to 
AD. Different analytical techniques such as, light scattering, filtration assay, electron 
microscopy and nuclear magnetic resonance (NMR) spectroscopy has been used to 
characterize the effect of anesthetic drugs on proteins related to AD through enhancement of 
peptide oligomerization (Pravat et al. 2006, Eckenhoff et al. 2004). 
 
AD is characterized by the accumulation of β-Amyloid 40/42 peptides in senile plaques and 
also the presence of neurofibrillary tangles inside the neurons (Cerf et al. 2009, Atassi 2006). 
Multiple studies have shown that in the cases of AD the levels of β-Amyloid peptide in 
cerebrospinal fluid are often low (Ramirez et al. 2010). 
It has been found that high concentrations of  Fe+3, Cu+2, and Zn+2 are found in the neurophils 
of AD patients and on within the core and periphery senile plaques. It has been suggested that 
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as a result of binding between metal ions and Aβ the kinetic energy barrier for Aβ 
precipitation is lowered (Lee 2010, Duce et al. 2010). 
A promising alternative to the pharmacotherapy for AD is the inhibition of oligomerization 
using small molecules or peptides that can induce Aβ to fold into α-helix or random rather 
than β-sheet and so block β-Amyloid aggregation (Kumar 2011). 
 
2.6  Propofol 
 
Propofol (2,6-Diisopropylphenol) is a non barbiturate, sedative, hypotonic agent. Propofol is 
the prototype of parental anesthetics; Anesthetics are drugs that causes anesthesia (Miller & 
Pardo 2011). Propofol appears as a milky white solution, because it is formulated in a solution 
with soybean oil, glycerol and egg phospholipids (Aschenbrenner  & Venable 2009, 
Silverstein et al. 2008). The Pka for propofol is 11 and pH is 7-8.5, its molecular weight is 
178.27g/mol, and it is slightly soluble in water. It has also shown anti-oxidant activity because 
of the presence of phenolic hydroxyl group in its structure. The negative ionotropic effect of 
propofol is due to reduced myocardial intracellular calcium availability caused by Ca+2 influx 
inhabitation (Collins & Dawes 2007). 
Propofol is important for maintenance of anesthesia. It is highly lipophilic drug that is rapidly 
distributed into vessel-rich organs. It is administrated intravenously and is distributed fast to 
all tissues in the body, loss of consciousness usually occurring within 40 seconds (cote, 2009). 
Its cumulative effect in the body is low, since it is extensively metabolized by hepatic 
enzymes. It has some benefits over other induction agents such that it is associated with more 
rapid awakening and recovery, with a less residual CNS (Central Nervous System) (Miloroet 
al.  2004). 
Propofol is metabolized by the lever by hepatic conjugation to be later excreted by the 
kidneys; about 50% of the metabolic byproducts are in the form of glucuronide conjugate. The 
elimination half life of propofol is 0.5-1.5 hours (Curey & Garavaglia 2008). The chemical 
structure for propofol is shown in (Fig 2.17) 
  
2.7  L
 
L-arg
The 
L-arg
net L
other
has a
interm
The 
and 
cashe
struc
F
-Arginin 
inine is a 
first discov
inine is ob
-arginine s
 site of L-a
 lot of fu
ediate in t
best dietary
milk produ
ws, Brazi
ture of L-ar
igure 2.17:
complex am
ery of L-arg
tained from
ynthesis is
rginine syn
nctions, it 
he urea cyc
 sources o
cts, other 
l nuts, cho
ginine is sh
Figure 2-1
 Chemical s
ino acid th
inine was 
 the diet al
 the kidney
thesis is th
plays a ro
le (Ignarro
f L-Arginin
foods cont
colate, bro
own in (Fig
8: Chemic
31
tructure of
at is found
in 1886 wh
though mam
, accountin
e liver (M.
le in the s
 2000, Rice
e are meat
aining sign
wn rice, 
 2.18). 
al structure 
 Propofol (M
 in the act
en it was fi
mals can 
g for abou
 Stayton200
ynthesis in
 & Correl 2
, peanuts, 
ificant am
and corn 
of Arginine
iloro et al
ive site of 
rst isolated
synthesize 
t 60% of 
8). L-Argi
numerable 
008 ).  
soybeans, h
ount of L-
(Stargrove 
 (Ignarro 2
 
. 2004). 
proteins an
 from lupin
it. The main
L-arginine 
nine is glyc
proteins, a
azelnut, sh
Arginine a
2008). Th
 
000). 
d enzymes
e seedlings
 site of the
stores. The
ogenic and
nd it is an
rimp, eggs
re almond
e chemica
. 
, 
 
 
 
 
, 
, 
l 
32 
 
2.8  Beta-Amyloid (Aβ) 
 
Aβ is a peptide of (35-43) amino acids that is generated by sequential intracellular cleavage of 
Amyloid Precursor Protein (APP) by β and γ secretases. APP is an oriented membrane protein 
of unclear function with its amino terminus within the lumen/extracellular space and its 
carboxyl terminus within the cytosol. APP is subjected to two principle processing pathways 
the amyloidogenic pathway and a non amyloidogenic one, β-Amyloid is produced during 
amyloidogenic pathway by consecutive action of β and γ secretases (Takahashi 2002, Lee 
2010). In anti amyloidogenic pathway APP is cleaved approximately in the middle of β-
Amyloid region by α-secretase, and so enhancement of α-secretase lowers the formation of 
amyloid plaques (Haass et al. 2012, planque 2007). “Cell biological studies have demonstrated 
that β-Amyloid is generated in the Endoplasmic reticulum (ER), Golgi, and 
endosomsl/lysosomal system” (Takahashi 2002, Haass et al. 2012). 
 
The sequence of amino acids in Aβ(1-40) is [H-Asp-Ala-Glu-Phe-Arg-His-Asp-Ser-Gly-Tyr-
Glu-Val-His-His-Gln-Lys-Leu-Val-Phe-Phe-Ala-Glu-Asp-Val-Gly-Ser-Asn-Lys-Gly-Ala-Ile-
Ile-Gly-Leu-Met-Val-Gly-Gly-Val-Val-OH] (Tjernberg et al. 1998). 
 
Studies on Aβ have been done and they have shown that due to the toxicity of Aβ, fibrillar Aβ 
can directly kill the neurons or initiate a series of events leading to neuronal cell death (Walsh 
et al. 1999). 
 
 Depending on environment, the cleavage sites, and on many other factors, these hydrophobic, 
unstable peptides self associate and a change in the secondary structure from α-helix and 
random coils to β-sheet are induced (Eckenhoff et al.  2004, Chiti 2009,  Pravat et al.  2006). 
 β-Amyloid fibrilization passes multiple of steps as shown in (Fig. 2.19). It involves formation 
of dimmers then small larger soluble oligomers, which are soluble spherical aggregates of 2-
20nm. Oligomers formation is followed by protofibrills formation leading to insoluble fibrils 
and consequently forming β-Amyloid plaques or deposits (Kumar 2011, Walsh et al.1999, 
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Vetri 2010, Jimenez 2005). Amyloid fibrils tend to be long (> 1µm), thin (10-20 nm) straight 
and unbranching (Krebs et al. 2005). 
 
 
Figure 2.19: self assembly of β-Amyloid protein (a) amyloid-β protein oligomer, (b) proto-
fibril, (c) fibril, and (d) plaque deposit (Kumar et al. 2011). 
 
It has been proven through studying the β-amyloid conformation during protofibrill and fibril 
assembly that during the conversion of unstructured, unassembled β-Amyloid into β-sheet rich 
fibril as a transition mode an increase in α-helix content occurs (Kirkitadze et al. 2001,  
Juszczyk 2009, Cerf et al. 2009, Wang 2008). Because of amyloid fibrils noncrystallinity and 
insolubility it was difficult to obtain high resolution fibril structure, so neither the assembly 
mechanism nor the atomic structure of the amyloid fibrils are known, but some few general 
principles that governs protein aggregation have been suggested (Thirumalai et al. 2003). 
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It has been revealed that FTIR can be used to study the aggregation properties of Aβ peptides, 
and the effect of environmental variables on aggregation. Investigations have shown that Aβ 
peptides are weakly soluble in physiological conditions, and the conformation of these 
peptides in a solution is highly dependent on the solvent itself, Ph, temperature, pressure, and 
the presence of co-solvent (Szabo et al.1999, Lee 2010, Chiti & Dobson 2009, planque 2007). 
It is now widely accepted that soluble oligomers of Aβ are more neurotoxic and play a role in 
amyloid pathogenesis than Aβ fibrils (Cerf et al. 2009, Vetri, 2010, Wang 2008).  
It has been discovered that Aβ (1-42) and Aβ (1-40) are the two major components of 
Amyloid plaques (Cerf et al. 2009, Atassi 2006, planque 2007, Lin 2003). NMR studies have 
shown that monomers of Aβ(1-40) and Aβ(1-42) have no α-helical or β-sheet structure, and 
they exist as random extended chains (Atassi 2006). 
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Chapter three: 
 
Experimental part 
 
 
  
36 
 
In this chapter experimental procedure has been discussed in details including sample 
preparation for FTIR, UV-vis spectroscopy, fluorescence spectroscopy, and AFM. The 
instrumentation of Fluorospectrometer (NanoDrop 3300), UV-vis spectrometer (NanoDrop 
1000), Bruker IFS 66/S, and Micro cantilever, OLYMPUS spectrometer has been discussed 
briefly. The experimental procedure followed in this research has been explained. 
 
3.1  SAMPLES PREPARATION 
 
In this study Aβ (1-40) have been used in powder form. It has a molecular weight of about 
(4329.82 AMU), with the chemical formula (C194H295N53O58S), and propofol (2, 6-
Diisopropylphenol) in solution form with a chemical formula (C12H18O) and a molecular 
weight (178.3 g/mol).  As for L-arginine in powder form with chemical formula (C6H14N4O2) 
and a molecular weight (174.2 g/mol), and phosphate buffer saline were used to prepare all the 
samples. All above chemicals were purchased from Sigma Aldrich Company and used without 
further purification. Optical grade silicon windows (NICODOM Ltd) were used as 
spectroscopic cell windows. These windows were purchased from Sigma Aldrich Company. 
FTIR measurements were carried out using several samples in the form of thin films of Aβ, 
Aβ-propofol, and Aβ-L-arginine solutions. UV-vis and fluorescence measurements were done 
using the liquid samples of the mentioned solutions. 
 
3.1.1. Stock solutions: 
 
Beta-Amyloid stock solution: 
0.5 mg of Aβ (1-40) was dissolved in 250 µl of triple distilled water to yield a concentration of 
0.462 mM. 
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Propofol stock solutions:  
The density of propofol is 962 gL-1, the molarity of propofol solution was found to be 5.396M. 
This solution was used to prepare different solutions with these concentrations of propofol 
(3.82, 2.88, 1.92, 1.44, 0.96, and 0.72 mM) using phosphate buffer saline (PBS) (pH 7.4) and 
depending on the molarity dilution equation (MiVi = MfVf). 
PBS pH 7.4 was directly prepared by dissolving one foil pouch in one liter double distilled 
water. 
 
L-Arginine stock solutions: 
1.338 mg of L-arginine was dissolved in 2 ml of PBS to prepare 3.84mM arginine stock 
solution. Different concentrations of L-arginine (3.84, 2.88, 1.92, 1.44, 0.96, 0.72, and 0.48 
mM) were prepared in PBS solution using molarity dilution equation. 
 
3.1.2.  Aβ-ligand solutions: 
 
The final concentration of  Aβ-propofol solution were prepared by mixing equal volumes of 
Aβ and propofol stock solutions. Aβ concentration in all samples will be 0.231mM, and the 
propofol concentrations in the final protein-drug solution are (1.92, 1.44, 0.96, 0.72, 0.48, 
0.36, and.0.24mM). 
 
The final concentrations of Aβ-arginine samples were prepared by mixing equal volumes of 
Aβ and L-arginine stock solutions. Aβ concentration in all samples will be 0.231mM, and the 
arginine concentrations in the final protein-drug solution are (1.92, 1.44, 0.96, 0.72, 0.48, 0.36, 
and.0.24mM). 
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3.1.3. Thin films preparation: 
 
After cleaning silicon windows very well, 40 µL of each sample were applied on a certain area 
on the silicon window plate and left to dry at room temperature inside the incubator for 24 
hours. The dehydrated films are prepared with the desired concentration of propofol and L-
arginine while keeping the concentration of Aβ constant in all of them. 
 
For background measurement, a clean silicon window has been kept in the same incubator 
together with the rest of samples, in order to have all samples in the same environment. 
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3.2 Instruments 
 
The following instruments are used in taking the required measurements: 
 
3.2.1. Fluorospectrometer: 
 
Fluorescence measurements had been done using Flourospectrometer (NanoDrop ND-3300) at 
250C. 
 The excitation source comes from one of three solid-state light emitting diodes (LED’s), 
which are oriented 90° to the detector. A 2048-element CCD array detector, covering 400 – 
750 nm, is connected by an optical fiber to the optical measurement surface. The spectrometer 
is configured with a cut filter to eliminate light transmission below 395 nm. 
A 1-2 µl sample is pipette onto the end of the lower measurement pedestal (the receiving 
fiber). A non-reflective “bushing” attached to the arm is then brought into contact with the 
liquid sample causing the liquid to bridge the gap between it and the receiving fiber. The gap, 
or path length, is controlled to 1mm. Following excitation with one of the three LEDs, emitted 
light from the sample passing through the receiving fiber is captured by the spectrometer. The 
NanoDrop 3300 is controlled by software run from a PC. The image below lists some of 
common fluorophores that can be measured using the NanoDrop 3300 along with the most 
appropriate excitation LED. 
The excitation source option includes the UV-LED with maximum excitation at 365nm, the 
blue-LED with maximum excitation at 470nm, and the white-LED in the range 500-650nm. 
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Figure 3.1:Excitation LEDs. 
 
3.2.2. UV-VIS spectrophotometer: 
 
The Thermo Scientific NanoDrop 1000 Spectrophotometer measures 1 µl samples with high 
accuracy and reproducibility. The full spectrum (220nm-750nm) spectrophotometer utilizes 
sample retention technology that employs surface tension alone to hold the sample in place. 
This eliminates the need for cumbersome cuvettes and other sample containment devices and 
allows for clean up in seconds. In addition, the NanoDrop 1000 Spectrophotometer has the 
capability to measure highly concentrated samples without dilution (50X higher concentration 
than the samples measured by a standard cuvette spectrophotometer). 
The sample is pipette at the end of a fiber optic cable, and then a second fiber optic cable is 
brought in contact with the sample causing the liquid to bridge the gap between the fiber optic 
ends which is controlled between 1-0.2mm. A pulsed xenon flash lamp provides the light 
source that pass through the sample. The excitation is made at 210nm and emission occurs at 
280nm.  
The sample size is not critical but the liquid column must be formed so that the gap between 
the upper and lower pedestals is bridged with the sample. 
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3.2.3. Fourier Transform Infrared Spectroscopy (FTIR): 
 
The FTIR measurements were obtained on Bruker IFS 66/S spectrophotometer, equipped with 
liquid nitrogen –cooled MCT detector and a KBr beam splitter the spectrometer was 
continuously purged with dry air during measurement. The absorption spectrums in the mid 
infrared region (4000-400 cm-1) were taken and measured. 
Because of the need to a relative scale for the absorption intensity, a background spectrum 
must also be measured. This is normally a measurement with no sample in the beam. 
 
The two most popular detectors for a FTIR spectrometer are deuterated triglycine sulfate 
(DTGS) which is a pyroelectric detector that delivers rapid responses because it measures the 
changes in temperature rather than the value of temperature, and “our detector” mercury 
cadmium telluride (MCT) which is a photon (or quantum) detector that depends on the 
quantum nature of radiation and also exhibits very fast responses. It must be maintained at 
liquid nitrogen temperature (77 °K) to be effective. Generally MCT detectors are faster more 
sensitive than DTGS detectors. 
 
3.2.4. Atomic force microscopy (AFM): 
 
Images for the surface of the samples have been taken using (Olympus, tips). The motion of 
the probe across the surface is controlled using feedback loop or piezoelectronic scanners. A 
semiconductor diode laser is bounced off the back of the cantilever onto a position suitable for 
photodiode detector. This detector measures the bending of the cantilever while the tip is 
scanning over the sample. The measured deflections are then used to generate a map for the 
surface topography (Wilson & Bullen). 
 
Other equipments were used in sample preparation and making measurements such as Digital 
balance, vortex, incubator, plate stirr, micropipettes, volumetric flask, beakers, and test tubes. 
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3.3 Experimental Procedures 
 
3.3.1. Fluorospectrometer procedure: 
 
The prepared liquid samples of Aβ free, Aβ-propofol and 
 Aβ-L-arginine solutions were used to make the fluorescence 
 Measurements in the following steps: 
 
With the sampling arm open, pipette the sample onto the 
lower measurement pedestal.  
 
 
Close the sampling arm and initiate a measurement using 
the operating software on the PC. The sample column is 
automatically drawn between the upper bushing and the 
lower measurement pedestal and the measurement is made. 
When the measurement is complete, open the sampling 
arm and blot the sample from both the upper bushing and 
the lower pedestal using low lint laboratory wipe to 
prevent sample carryover and avoid residue buildup  
  
 
3.3.2. UV-VIS spectrometer (ND-1000): 
 
The same samples used in UV-vis measurements were used 
following these steps: 
With the sampling arm open, pipette the sample onto the 
 lower measurement pedestal.  
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Close the sampling arm and initiate a spectral 
measurement using the operating software on the 
PC. The sample column is automatically drawn 
between the upper and lower measurement 
pedestals and the spectral measurement made.  
 
 
When the measurement is complete, open the 
sampling arm and wipe the sample from both the 
upper and lower pedestals using a soft laboratory 
wipe. Simple wiping prevents sample carryover in 
successive measurements. 
 
When the NanoDrop ND-1000 and NanoDrop ND-3300 spectrophotometers are blanked, a 
spectrum is taken for the reference material, and stored in computer memory as an array of 
light intensities by wavelength. When a measurement of a sample is taken the intensity of light 
that has been transmitted through the sample is recorded, and then the sample intensity with 
the blank intensity was used to calculate the sample absorbance according to the following 
equation: 
Absorbance = A = -log ( Intensity sample / Intensity blank) 
Both the intensity of the blank and of the sample is needed to give the absorbance at a given 
wavelength. 
 
3.3.3. Fourier Transform infrared (FTIR) spectroscopy: 
 
The nitrogen gas cylinder is switched on by turning the switch on the top of the cylinder anti-
clockwise. When the gas reaches the mirror then a green led will start flashing at the base of 
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the spectrometer. Liquid nitrogen must be employed inside the instrument and the prepared 
samples then can be delivered starting with the background sample. 
Each measurement is taken at a resolution of 4 cm-1 and an average 60 scans to increase signal 
to noise ratio, the aperture used in this study was 8mm, since it has been founded that this 
aperture gives best signal to noise ratio. Many manipulation techniques have been performed 
on all the spectra by OPUS software (Optic User Software) such as baseline correction, 
normalization, and peak areas calculations. The peak positions were determined using second 
derivative of the spectra. 
For temperature dependence study Aβ-drug complexes on silicon windows were placed into 
an infrared cell window. The temperature of the cell was controlled by an external water path 
and was increased gradually from 200C to 800C at 30C per 5 minutes scan rate.  
Peak positions were determined using second derivative at 9 smoothing points by OPUS 
software, calculation of areas under the different curves were performed using Fourier self 
deconvolution (FSD) techniques by OPUS software. 
The advantages of the FTIR instrument is the high speed and sensitivity, as it acquire the 
interferogram in less than a second. Modern FTIR spectrometers have a powerful 
computerized data system, as it can perform many data processing tasks (Jilie Kong, 2007), a 
brief explanation of these tasks is given below: 
1. Baseline correction: 
The offset correction is performed by selecting a single point of multiple points on a spectrum 
and adding to them or subtract a y-value to correct the baseline offset. This processing step is 
used to bring the minimum point to zero, or to align the baseline of two or more spectra 
causing them to overlap. 
 
2. Derivatives:  
Derivatives are used to remove offset and slope due to background differences. In our study 
we have used second derivative to determine the positions of peaks for Aβ-free, Aβ-Propofol 
complexes, and Aβ-L-arginine complexes. 
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3. Fourier self deconvolution: 
It is the band narrowing technique that is most widely used in infrared spectroscopy of 
biological material. The aim of FSD is to enhance the apparent resolution of a spectrum, or to 
decrease the line width. So the broad and overlapping lines of spectrum can be separated into 
sharp single lines. 
The deconvolution correspond to a multiplication of the interferogram I(x) using the ݁ݔ݌௔௫  
deconvolution function for Lorentzian and ݁ݔ݌௔௫మ  for Gaussian shapes, which will intensifies 
the interferogram edges. 
The deconvolution factor is the maximum value of these functions at the end of the 
interferogram, deconvolution factors of 100, 1000, and 5000 correspond to a maximum 
amplification of 3.4, 12.8, and 40 in the case of Lorentzian shape, and 1.06, 3.2, and 16 in the 
case of Gaussian shapes. If you work with Lorentzian shapes it is recommended to increase 
the deconvolution factor in the order of 50, 100, 1000, 5000, and to stop if the resultant 
spectrum shows artificial oscillations (Bruker, 2004). Successful application of FSD will 
enhance peak separation on overlapping absorption bands. The application of FSD on amide I, 
and amide II regions is a key step in the determination of proteins secondary structure, 
conformational changes, structural dynamics and stability studies of proteins. ( Jilie Kong 
2007) 
 
4. Curve fitting: 
The curve fitting command allows calculating single components in a system of overlapping 
bands, a model that consists of an estimated number of bands. A baseline should be generated 
before the fitting calculation is started. The model can be set up interactively on the display 
and is optimized during the calculation (Brucker, 2004). 
 
3.3.4. Atomic force microscopy:  
 
AFM is used to give high resolution picture for Aβ-free, Aβ-propofol , and Aβ-L-arginine 
solutions. 10 µl of the liquid Aβ-drug solution after washing with water to remove un-
adsorbed material was placed on a certain area of a freshly cleaved mica substrate and left to 
46 
 
dry at room temperature. Aβ free, Aβ-propofol, and Aβ-L-arginine solutions were 
characterized by AFM equipped with 4x4µm2 piezoelectric scanner. Analysis was carried out 
using tapping mode at room temperature using AFM cantilevers with a spring constant 2N/m 
(Micro cantilever, OLYMPUS). All scanned images were analyzed using WSxM 5.0 Develop 
3.2 software. 
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Chapter Four 
 
 
Results and discussion 
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The experimental results are presented as follows: the first section deals with UV-absorption 
spectroscopy. The second section discusses fluorescence spectroscopy results. The third 
section discusses Fourier transform infrared spectroscopy results. In the last section AFM 
images for Aβ free and Aβ-propofol complexes and Aβ-L-arginine complexes will be shown. 
 
4.1 UV-absorption spectroscopy 
 
UV-absorption spectroscopy was used to determine the binding constants between Aβ and a 
drug (propofol or arginine). The strength of interaction between Aβ and drugs is dependent on 
the binding constant which can be calculated using graphical analysis of the absorbance 
spectrum. 
The absorption spectra for Aβ-propofol and Aβ- L-arginine complexes with different 
concentrations of propofol and L-arginine were recorded and shown in (Fig 4.1, and 4.2 
respectively). The excitation has been done at 210 nm, while the absorption is recorded at 280 
nm. The UV absorbance intensity of Aβ has increased with increasing propofol concentration, 
while it has decreased with increasing L-arginine concentration. The change in the absorbance 
intensity of Aβ with increasing drug concentration is an indication that an interaction has 
occurred between Aβ and propofol and L-arginine. 
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Figure 4.1: UV absorbance spectra of Aβ-propofol complexes at different propofol 
concentrations (a: 0.0mM, b: 0.36mM, c: 0.48mM, d: 0.72mM, e: 0.96mM, f:1.44mM, and g: 
1.92mM) 
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Figure 4.2: UV absorbance spectra of Aβ-L-arginine complexes at different L-arginine 
concentrations (a: 0.0mM, b: 0.36mM, c: 0.48mM, d: 0.72mM, e: 0.96mM, f: 1.44mM, and g: 
1.92mM) 
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4.1.1. Determination of binding constants (K) by UV absorption spectroscopy: 
 
To determine the binding constant (k) by UV-Vis. spectroscopy a plot of  ଵ
஺ି஺బ
 vs ଵ
௅
 is made. 
This plot indicates a linear relation and the binding constant (k) is found by taking the ratio of 
the intercept to the slope, which can be seen clearly from the following equation (Darwish et 
al. 2012). 
1
ሺܣ െ ܣ଴ሻ
ൌ
1
ሺܣஶିܣ଴ሻ
൅  
1
ܭሺܣஶ െ ܣ଴ሻ
 
1
ܮ 
 
Where ܣ଴ corresponds to the absorption of protein at 280nm in the absence of a ligand, while 
ܣஶ is the final absorption of protein after it binds to the ligand, and ܣ is the recorded 
absorption at the different concentrations of the ligand (L), the ligand in our  case is either 
propofol or L-arginine. 
A plot of ଵ
஺ି஺బ
 vs. ଵ
௅
 for different concentrations of propofol in Aβ-propofol complexes is 
shown in (Fig.  4.3), and for different concentrations of L-arginine in Aβ-L-arginine 
complexes is shown in (Fig. 4.4). 
The binding constant for Aβ-propofol is calculated to be 2.13 ൈ 10ଶ M-1, and for Aβ-L-
arginine complexes is calculated to be 0.35 ൈ 102M-1. The binding constant for Aβ-L-arginine 
is lower than that of Aβ-propofol. Drugs with low binding constants are shown to be more 
effective in binding with protein (Bhattacharya et al 2000). 
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Figure 4.3: the plot of ଵ
஺ି஺బ
 vs ଵ
௅
 for Aβ with different concentrations of propofol. 
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Figure 4.4: the plot of ଵ
୅ି୅బ
 vs ଵ
୐
 for Aβ with different concentrations of L-arginine. 
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4.2 Fluorescence spectroscopy 
 
Fluorescence spectroscopy is another technique that is used widely to study binding between 
protein and ligand. In Aβ(1-40)  intrinsic fluorescence is mainly due to tyrosine (tyr) residue, 
since no tryptophan (Try) is found in the structure of Aβ(1-40) and phenylalanine (Phe) has 
very low quantum yield (Sarroukh et al. 2011, Amaro et al. 2013). 
Various molecular interactions can decrease the fluorescence intensity of a compound such as 
molecular rearrangements, exited state reactions, energy transfer, ground state complex 
formation, and collisional quenching (Turro 1991, Sheehan 2009). The excitation is done on 
350 nm and emission occurs at 431 nm. 
The fluorescence emission spectra of Aβ with various concentrations of propofol (0.24, 0.36, 
0.48, 0.96, 1.44, and 1.92 mM) are shown in (Fig 4.5).The emission fluorescence spectra of 
Aβ with various L-arginine concentrations (0.24, 0.36, 0.48, 0.96, 1.44, and 1.92 mM) are 
shown in (Fig 4.6).  
  
55 
 
 
 
400 450 500 550
0
100
200
300
400
500
R
el
at
iv
e 
Fl
uo
re
sc
en
ce
 In
te
ns
ity
Wavelength (nm)
 
Figure 4.5: The fluorescence emission spectra of Aβ with various concentrations of propofol 
(a= 0.0, b=0.24, c= 0.36, d= 0.48, e= 0.96, f= 1.44, and g=1.92 mM) 
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Figure 4.6: The fluorescence emission spectra of Aβ with various concentrations of L-arginine 
(a=0.0, b=0.24, c=0.36, d=0.72, e=0.96, f=1.44, and g=1.92 mM) 
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4.2.1. Determination of Stern-Volmer quenching constants (Ksv) and the quenching rate 
constant (Kq): 
 
Fluorescence quenching can be induced by different mechanisms that were usually classified 
into static quenching and dynamic quenching. Dynamic quenching arises from collisional 
encounters between the fluorophores and quenchers while static quenching results from the 
formation of a ground state complex between the fluorophores and the quenchers (Turro 
1991). 
For dynamic quenching, the decrease in fluorescence intensity is described by Stern-Volmer 
equation (Lakowicz 2006, Sheehan 2009). 
ܨ଴
ܨ ൌ 1 ൅ ܭ௦௩ሾܮሿ ൌ 1 ൅ ݇௤߬଴ሾܮሿ 
Where F and F0 are the fluorescence intensities with and without quencher, ݇௤ is the 
quenching rate constant, ܭ௦௩ is the Stern-Volmer quenching constant, (L) is the concentration 
of propofol or L-arginine, and ߬଴ is the average lifetime of the biomolecule without quencher. 
The Stern-Volmer quenching constants ܭ௦௩  were obtained by finding the slope of the linear 
curve obtained when plotting ிబ
ி
 vs (L). The quenching rate constant  ݇௤ can be calculated 
using the fluorescence lifetime of Aβ to be 1.1ns (Amaro et al.2013). 
The plots of ிబ
ி
 vs [L] for Aβ-propofol and Aβ-arginine complexes are shown in (Fig 4.7, and 
4.8 respectively). From these plots the Stern-Volmer quenching constants for Aβ-propofol and 
Aβ-L-arginine complexes were found to be 1.21 ൈ103 M and 1.49 ൈ 10ଷ M respectively. The 
quenching rate constants for Aβ-propofol and Aβ-arginine were then calculated to be 1.1 ൈ 
1012 L Mol-1 s-1 and 1.35ൈ1012 L Mol-1 s-1 respectively. The obtained values of the quenching 
rate constants for both propofol and L-arginine are larger than the maximum dynamic 
quenching constants for various quenchers with biopolymers (2ൈ1010 L Mol-1 s-1) which 
confirms that static quenching is dominant in these complexes (Wang et al. 2008, Darwish et 
al. 2012). 
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Figure 4.7: The plot of ிబ
ி
 vs [L] for Aβ-propofol 
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Figure 4.8: The plot of ிబ
ி
 vs [L] for Aβ-L-arginine 
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4.2.2. Determination of the binding constants (K) by fluorescence spectroscopy: 
 
For static quenching, the following equation is used to determine the binding constant between 
Aβ and the drug. 
1
ܨ଴ െ ܨ
ൌ
1
ܨ଴ܭሺܮሻ
൅
1
ܨ଴
 
Where ܭ is the binding constant of drug with Aβ. To determine the binding constants of Aβ-
propofol and Aβ-arginine systems, a plot of ଵ
ிబିி
 vs ଵ
௟
  for different propofol and L-arginine 
concentrations is made. The plots are linear and have a slope of ଵ
ிబ௄
  and intercept  ଵ
ிబ
 according 
to the above equation. By taking the quotient of the intercept and the slope, the binding 
constants K(L) can be calculated. 
 
The plot of ଵ
ிబିி
 vs 1/L for Aβ-propofol and Aβ-L-arginine complexes are shown in (Fig 4.9, 
and Fig 4.10 respectively). The binding constants for propofol and L-arginine with Aβ have 
been calculated from the slope and the intercept in (Fig. 4.9, and 4.10 respectively) and are 
found  to be  2.81ൈ 102 M-1 for Aβ-propofol and 0.37ൈ 102 M-1 for Aβ-L-arginine. 
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Figure 4.9: The plot of ଵ
ிబିி
 vs 1/L for Aβ-propofol complexes. 
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Figure 4.10: The plot of ଵ
ிబିி
 vs 1/L for Aβ-L-arginine complexes. 
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4.3 Fourier transform infrared (FTIR) spectroscopy 
 
FTIR spectroscopy has special characteristics made it suitable to analyze the protein-ligand 
interaction in all kinds of physiological conditions (Stuart 2004). These characteristics are the 
high sensitivity, fast analysis, and low demanding sample preparation (Susi & Bayler1983). 
The infrared spectra exhibit a number of amide bands and changes in these bands have been 
noticed and used to follow aggregation and to explore the effects of environmental properties 
and temperature on the structure of protein. Any changes in the molecular structure of the 
protein can be noticed from the changes in the amide regions, mainly amide I and amide II.  
Changes in the intensities of the absorption bands of β-sheets have been studied in great 
details. This research focused on β-sheets as it has been shown that amyloid fibrils are rich in 
β-sheet especially the more stable anti-parallel β-sheet (Kirkitadze et al. 2001, Juszczyk 2009, 
Cerf et al. 2009, Wang 2008, Zandomeneghi et al.2004). 
Amide I and amide II bands are the two most prominent vibrational bands of the protein 
backbone. The most sensitive spectral region for the protein secondary structure is the amide I 
band, therefore most investigations concentrated on amide I band (Kong & Yu 2007, Smith 
2011, Raaman 2006). 
In this study FTIR has been used to investigate the conformational changes in Aβ after binding 
to propofol and L-arginine. First we have studied changes in the peak positions of amide I and 
amide II regions for Aβ with different concentrations of propofol and L-arginine and at 
different temperatures. In addition the changes in the intensity of the component bands in the 
secondary structure of Aβ with changing propofol and L-arginine concentrations have been 
investigated. The effect of changing temperature on the intensity of β-sheet bands for Aβ free, 
Aβ-propofol complex, and Aβ-arginine complex have been examined. 
 
4.3.1. Peak positions: 
 
The second derivative technique and Fourier self deconvolution (FSD) can be used to obtain 
the peaks positions of the FTIR spectrum. The second derivative of the FTIR spectrum for Aβ-
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free in amide I and amide II bands are shown in (Fig 4.11.A, and Fig 4.12.A) The FTIR 
spectra of Aβ-propofol thin films with concentrations (0.0, 0.48, 0.72, 0.96, and 1.92mM), and 
the spectra of Aβ-L-arginine thin films with concentrations (0.0, 0.24, 0.36, 0.48, and 
0.72mM) are shown in (Fig 4.11.B, and 4.12.B respectively). 
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Figure 4.11: the spectra of A: Aβ free (second derivative) and B: Aβ-propofol complexes with 
concentrations (a=0.0mM, b= 0.48mM, c=0.72mM, d=1.44mM, and e=1.92 mM). 
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Figure 4.12: the spectra of A: Aβ free (second derivative) and B: Aβ-L-arginine complexes 
with concentrations (a=0.0mM, b= 0.24mM, c=0.36mM, d=0.48mM, and e=0.72 mM). 
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The peak positions of Aβ with different propofol and L-arginine concentrations in amide I and 
amide II are shown in (Table 4.1, Table 4.2 respectively). For Aβ-propofol spectrum we notice 
peak shifts in amide I band: 1622 to 1624 cm-1, 1636 to 1638 cm-1, 1661 to 1662 cm-1, 1693 to 
1694 cm-1, while the peak at 1677cm-1 has not been changed. In amide II region the shifts are: 
1489 to 1499 cm-1, 1509 to 1515 cm-1, 1528 to 1531 cm-1, 1551 to 1550 cm-1, 1666 to 1568 
cm-1, and 1591 to 1592 cm-1. 
For Aβ with different L-arginine concentrations in amide I band we notice peak shifts as 
follows: 1622 to 1621cm-1, 1636 to 1638cm-1, 1661 to 1662, 1677 to 1678cm-1, while the peak 
at 1693 cm-1 has not been shifted and the peak at 1608cm-1 has disappeared as its intensity was 
small and addition of L-arginine has reduced its intensity to zero. In amide II region the shifts 
are: 1489 to 1487 cm-1, 1509 to 1507 cm-1, 1528 to 1525cm-1, 1551 to 1548 cm-1, 1666 to 1568 
cm-1, and 1591 to 1593 cm-1. 
The peak shifts for Aβ-propofol system to a higher wave number can be attributed to a newly 
imposed hydrogen bonding on the C=O upon the addition of propofol (Sarver & Krueger 
1991, Lee 1986 ). In amide II region the peak shifts are more clear as we notice the shift from 
1489 to 1499 cm-1, and from 1509 to 1515 cm-1, the shifts indicates that the binding constant 
for the NH and CN bonds (which are responsible for the amide II spectra) (Kong & Yu 2007) 
has changed upon interaction with propofol. The shifts in these peaks are toward higher wave 
numbers which indicates that the strength of the bond has increased. On the other hand for Aβ-
L-arginine systems the shifts are toward smaller wavelength which indicates that the strength 
of the bond have been decreased upon L-arginine addition. 
The vibrational energy is proportional to the frequency of oscillation. Shifts to higher wave 
numbers means that the frequency of oscillation has increased and so a photon of higher 
energy is needed to break the bond and it can be said that shifts toward higher wave numbers 
indicates an increase in the strength in the bond and vice versa. 
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Table 4.1: Band assignment in the absorbance spectra of Aβ with different propofol 
concentrations in amide I, and amide II. 
Bands Aβ Aβ+Propofol Aβ+Propofol Aβ+Propofol Aβ+Propofol.  Aβ+Propofol 
   free  0.48mM  0.72mM 0.96mM 1.44mM 1.92mM 
  1608 1607 1607 1608 1608 1608 
  1622 1623 1623 1623 1624 1623 
Amide I 1636 1638 1638 1638 1637 1638 
  1661 1662 1662 1662 1662 1662 
1677 1677 1677 1677 1677 1676 
1693 1694 1694 1694 1694 1694 
  1489 1497 1496 1498 1498 1499 
1509 1511 1515 1514 1515 1515 
 Amide II 1528 1532 1531 1532 1532 1531 
1551 1550 1550 1550 1550 1550 
 
1566 1567 1569 1567 1567 1568 
  1591 1593 1592 1592 1592 1592 
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Table 4.2: Band assignment in the absorbance spectra of Aβ with different L-arginine 
concentrations in amide I, and amide II. 
Bands Aβ Aβ+L-aginine Aβ+L-arginine Aβ+L-arginine Aβ+L-arginine Aβ+L-arginine
free 0.24mM 0.36mM 0.48mM 0.72mM 1.92mM 
  1608 
  1622 1620 1621 1620 1620 1621 
Amide I 1636 1639 1639 1638 1638 1638 
  1661 1661 1661 1662 1662 1662 
  1677 1676 1676 1678 1677 1678 
  1693 1693 1692 1693 1692 1693 
  1489 1493 1487 1484 1487 1487 
  1509 1510 1506 1508 1509 1507 
Amide II 1528 1530 1521 1529 1526 1525 
  1551 1549 1546 1547 1546 1548 
  1566 1568 1567 1568 1567 1568 
  1591 1593 1593 1593 1593 
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The difference spectra [(protein + propofol or L-arginine) – (protein)] were obtained to show 
the intensity variation, and the results are shown in (Fig 4.13, and Fig 4.14). For Aβ-propofol 
interaction; (Fig 4.13 A) shows FTIR spectra in amide I and amide II regions. The difference 
spectra for Aβ with different propofol concentrations in amide I and amide II regions are 
shown in (Fig 4.13 B). 
In amide I region there is one strong positive feature at 1630 cm-1 in addition to a one weak 
positive feature at 1670 cm-1. For amide II region there is one strong positive feature at 1550 
cm-1. These features were obtained at propofol concentrations (0.48, 0.72, and 1.44 mM). 
For Aβ-L-arginine interaction: (Fig 4.14 A) shows FTIR spectra in amide I and amide II 
regions. (Fig 4.14 B) shows the difference spectra of Aβ with different L-arginine 
concentrations in amide I and amide II regions. In amide I region there is one strong negative 
feature at 1629 cm-1, and another weak negative feature at 1668 cm-1, while in amide II region 
there is one strong negative feature at 1538 cm-1 and another weak negative feature at 1493 
cm-1.  
It is clearly shown that the strong positive features in amide I and amide II become stronger as 
propofol concentration was increased, on the other hand the strong negative features in amide 
I and amide II become stronger with increasing L-arginine concentration except for the weak 
negative feature at 1493 cm-1 with a little shift in its position. 
The observed positive features are attributed to the increase in the intensity of the amide I 
band at 1630, and 1670 cm-1, and amide II band at 1550 cm-1 as a result of propofol interaction 
with Aβ. This increase in the intensity is due to the increase in the number of β-sheet bonds. 
(Darwish et al. 2012) The negative featured noticed in the difference spectra of [Aβ-(L-
arginine) – Aβ] are due to the decrease in the intensity with increasing L-arginine 
concentration. This decrease in the intensity is due to the decrease in the number of β-sheet 
bonds. 
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Figure 4.13: A: The FTIR spectra for Aβ free and Aβ-propofol complex 1.44mM, and B: 
difference spectra of Aβ and its complexes with different propofol concentrations in the region 
(1800-1480 cm-1). 
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Figure 4.14: A: The FTIR spectra for Aβ free and Aβ-L-arginine complex 0.72mM, and B: the 
difference spectra of Aβ and its complexes with different L-arginine concentrations in the 
region 1480-1800cm-1. 
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4.3.2.  Secondary structural changes: 
 
To determine the secondary structure of Aβ and its propofol or L-arginine complexes, the 
procedure described by Byler and Susi has been followed (Susi & Bayler 1983). A 
quantitative analysis of Aβ secondary structure for the free Aβ and for Aβ with different 
concentrations of propofol and L-arginine has been determined from the spectra of the amide 
I, and amide II bands. Baseline correction has been performed in the ranges (1700-1600 cm-1), 
and (1600-1480 cm-1), to bring the minimum point to zero and to align the baseline of all the 
spectra. FSD was applied in these two ranges to increase the resolution of spectra and estimate 
the position, the number, and the area of each component band. A curve fitting process has 
been carried out using OPUS software (version 5.5) to obtain the best Lorentzian shaped 
curves that fit the original spectrum.  
The major peaks in each amide band are contours of multiple peaks interfere. Every peak is 
assigned to a secondary structural element. On the basis of previous infrared studies on other 
proteins (Lee 1986, Sarroukh et al 2010, Darwish et al.2012), on Aβ(1-28) (Juszczyk 2008), 
and on Aβ(1-40) (Lin 2003). The amide I bands range 1600-1612 cm-1 are assigned to anti-
parallel β-sheet, 1612-1630cm-1  were assigned to parallel β-sheet, 1630 to 1650 cm-1  to 
random coil, 1650 to 1670 cm-1  to α-helix, 1670 to 1685 cm-1  to β-turns, and 1685 to 1700 
cm-1  to anti-parallel β-sheet (Lin 2003, Szabo et al.1999, Cerf et al. 2009).for amide II, the 
absorption bands consists of six bands assigned in the following order: 1480 to 1500 cm-1 to 
parallel β-sheet, 1500 to 1520 cm-1 to random coil, 1520 to 1538 cm-1 to anti parallel β-sheet, 
1538 to 1560 cm-1 to α-helix, 1560 to 1580 cm-1 to β-turns, and 1580 to 1600 cm-1 to anti-
parallel β-sheet (Li et al. 2009). 
Based on the above assignments, the percentages for each secondary structural element of Aβ 
and its propofol or L-arginine complexes have been calculated from the integrated areas of the 
component bands in amide I, and II respectively. The area of each structural element is found, 
then the areas are all summed, and then we divide the area of each element by the total area. 
The obtained number is taken as the proportion to the poly peptide chain component band 
responsible for that peak, and then the percentages of each secondary structural element were 
determined (Sarver & Krueger1991). 
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The secondary structure determination for the free Aβ - propofol complexes and Aβ-L-
arginine complexes are given in (Table 4.3, and Table 4.4 respectively). The curve fitted for 
amide I and amide II regions of the free Aβ (0.231 mM) and its propofol complex with 
propofol concentration of 1.44 mM, are shown in (Fig. 4.15). The curve fitted for amide I and 
amide II regions of the free Aβ (0.231 mM) and its L-arginine complex with arginine 
concentration of 0.72 mM, are shown in (Fig. 4.16) 
the changes in parallel and anti parallel β- sheet intensities with changing propofol and L-
arginine concentration while keeping Aβ concentration constant in amide I and amide II are 
shown in (Fig. 4.17) 
In amide I region, free Aβ composed of the components: random coil (31%), α-helix (25%), β-
sheet (35% of them 16% for parallel β-sheet and the remaining 19% for anti parallel β-sheet), 
and β-turns (8%). From (Table 4.3, and Fig. 4.16) the result of Aβ-propofol interaction shows 
that random coil structure has reduced from 31% to 28%, α-helical structure has increased 
from 25% to 29%, β-turn has increased from 8% to 10%, parallel β-sheet has decrease from 
16% to 10%, and anti-parallel β-sheet has increased from 19% to 23%. 
In amide II region free Aβ contained random coil (30%), α-helix (14%), parallel β-sheet 
(11%), anti parallel β-sheet (27%), and β-turns (19%), after interaction with propofol random 
coil has decreased from 30% to 12%, α-helix from 14% to 10%, parallel β-sheet from 11% to 
6%, anti-parallel β-sheet has increase from 27% to 47%, and β-turn has increased from 19% to 
24%. 
It can be seen from (Table 4.4, and Fig. 4.8) that is as a result of Aβ-arginine interaction that 
the random coil structure has increase from 31% to 42%, α-helical structure has increased 
from 24% to 30%, β-turn has decreased from 9% to 5%, parallel β-sheet has decrease from 
16% to 10%, and anti-parallel β-sheet has decreased from 20% to 13%. 
In amide II region, after interaction with L-arginine random coil has increased from 30% to 
39%, α-helix has increased from 14% to 28%, parallel β-sheet has decreased from 11% to 7%, 
anti-parallel β-sheet has decreased from 27% to 10%, and β-turn has decreased from 19% to 
15%. 
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The parallel β-sheet arrangement is weaker than anti-parallel one and less stable because of its 
geometry of the individual amino acids composing it, which will force the hydrogen bond to 
occur at an angle which will make them longer and weaker, on the other hand in anti parallel 
arrangements the amino acids are directed opposite to each other and so hydrogen bonds 
between carbonyl and amines will be planar and the arrangement is stronger and more stable 
(Perczel et al.2005, Irie et al. 2005). 
In the analysis of the absorption spectra for Aβ-propofol complexes in amide I and amide II , 
the relative intensity of  parallel β-sheet with its peak at (1623 cm-1) shows a decrease with 
increasing propofol concentration (Fig 4.17 A). the same observation can be made for parallel 
β-sheet band at (1486 cm-1) in the amide II as shown in (Fig. 4.17 B).on the other hands an 
increase in anti-parallel β-sheet component which has peaks at (1694 cm-1) in amide I as shown 
in (Fig. 4.17A) and at (1522 and 1593 cm-1) in amide II as shown in (Fig 4.17 B). The 
decrease in the parallel β-sheet intensity percentage accompanied with increase in anti-parallel 
β-sheet structures are believed to be due to the unfolding of protein in the presence of propofol 
as a result of H-bonding formation between propofol and Aβ (zandomeneghi et al. 2004). 
Circular dichroism (CD), FTIR spectroscopy, and X-ray diffraction studies confirmed that 
amyloid fibrils have a β-pleated sheet structure (A. Lomakin 1996, Zandomeneghi 2004). The 
observed increase in the intensity of anti-parallel β-sheet as a result of Aβ interaction with 
propofol is an indication of fibrils formation (Sarroukh 2010, Juszczyk 2008). These changes 
can also be noted directly from the curve fitted curves in (Fig. 4.16).  
In the analysis of the absorption spectra of Aβ-L-arginine complexes in amide I and amide II, 
both parallel and anti-parallel β-sheet intensity shows a gradual decrease with increasing L-
arginine concentration as shown in (Fig. 4.17 C, and 4.17 D), which is a good indication of the 
effect of L-arginine in decreasing oligomerization by converting the insoluble (β-sheet rich) 
fibrils or oligomers into a more soluble entities. 
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Table 4.3: secondary structure determination for amide I, and amide II regions for Aβ and its 
propofol complexes. 
Bands Aβ free Aβ+propofol 
0.48 mM 
Aβ+propofol 
0.72 mM 
Aβ+propofol 
0.96 mM 
Aβ+propofol 
1.44 mM 
Amide I           
antiparallel β-Sheets 0.2 0.2 0.2 0.2 0.2 
1600-1610      
parallel  β-Sheets 16.3 14.0 11.2 12.0 10.1 
1610-1629cm-1      
  Random Coil 31.4 29.7 29.7 30.7 28.2 
  (1629-1650 cm-1) 
   α-helix 24.8 27.3 27.7 28.2 28.7 
  (1650-1669 cm-1) 
  β-turns 8.4 9.4 10.5 9.2 10.1 
  (1669-1685cm-1) 
  Antiparallel β-Sheets 18.9 19.4 20.7 19.7 22.7 
  (1685-1700 cm-1) 
      
Amide II      
Parallel β-sheet 10.8 6.0 5.0 5.0 5.6 
1480-1500 
Random Coil 29.9 27.4 14.1 16.4 12.2 
  (1500-1520 cm-1) 
 anti-Parallel β-sheet 15.5 18.9 25 22.5 26.6 
  (1520-1540 cm-1) 
α-helix 13.8 
 
13.7 
 
12.0 
 
12.3 
 
10.4 
   (1540-1560 cm-1) 
β-turns 18.8 20.7 25.3 24.3 24.1 
  (1560-1580 cm-1) 
Anti-parallel β-sheet 11.2 13.3 18.7 19.4 21.0 
1580-1600 
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Table 4.4: secondary structure determination for amide I, and amide II regions for Aβ and its 
L-arginine complexes. 
Bands Aβ free Aβ+L-arginine 
0.24mM 
Aβ+L-arginine  
0.36 mM 
Aβ+L-arginine 
0.48 mM 
Aβ+L-arginine 
0.72 mM 
Amide I           
Antiparallel β-Sheets 0.2 0.2 0.2 0.1 0.1 
(1600-1610 cm-1)      
parallel  β-Sheets 16.3 11.2 10.7 8.6 10.2 
1610-1629cm-1      
  Random Coil 31.4 35.4 36.7 40.4 42.1 
  (1629-1650 cm-1) 
 α-helix 24.8 28.0 29.8 31.7 30.0 
  (1650-1669 cm-1) 
  β-turns 8.4 7.6 7.3 6.0 4.7 
  (1669-1685cm-1) 
Antiparallel β-Sheets 18.9 17.6 15.3 13.2 12.9 
  (1685-1700 cm-1)      
       
Amide II      
 Parallel β-sheet 10.8 10.9 7.7 7.5 7.3 
1480-1495 
  Random Coil 29.9 33.6 37.1 38.9 39.2 
1498-1515 
Anti-parallel β-Sheets 15.5 14.7 11.4 10.9 9.9 
1515-1538 
α-helix 13.8 
 
17.1 22.1 25.4 28.3 
1538-1560 
β-turns 18.8 14.6 15.3 15.0 15 
1560-1577 
anti-parallel  β-Sheets 11.2 9.2 6.4 2.3 0.4 
1577-1600 
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Figure 4.15: Curve fitted graphs for (A) free Aβ in amide I region, (B) Aβ-prop. Complex with 
1.44mM Propofol concentration in amide I region, (C) free Aβ in amide II region, (D) Aβ-
propofol complex with 1.44mM Propofol concentration in amide II region. 
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Figure 4.16: Curve fitted graphs for (A)free Aβ in amide 1 region, (B) Aβ-L-arginine. 
Complex with 0.72 mM L-arginine concentration in amide 1 region, (C) free Aβ in amide II 
region, (D) Aβ-L-arginine complex with 0.72mM L-arginine concentration in amide II region. 
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Figure 4.17:  Relative intensity variation for different concentrations of A: Aβ-propofol 
complexes in amide I region, B: Aβ-propofol complexes in amide II region, C: Aβ-L-arginine 
complexes in amide I region, D: Aβ-L-arginine complexes in amide II region. 
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4.3.3. Effect of temperature: 
 
The effect of increasing temperature on Aβ free, Aβ-propofol complex, and Aβ-L-arginine 
complex have been studied in both amide I and amide II bands. The effects of increasing 
temperature on parallel and anti-parallel β-sheet in amide I were shown in (Fig. 4.18 A,B, and 
C respectively).  The effects of increasing temperature on parallel and anti-parallel β-sheet in 
amide II were shown in (Fig. 4.19 A,B, and C respectively). 
For Aβ free no appreciable shifts in peaks are noticed. No changes in parallel or anti parallel 
β-sheet composition is noticed with increasing temperature in both amide I and amide II as 
shown in (Fig4.18 A, and 4.19 A). 
For Aβ propofol complex upon the analysis of the spectra of Aβ-propofol complex with 
changing temperature from (20 to 80 C0) it is noticed that: peaks have little or no appreciable 
shifts in their positions, the intensity for the bands of parallel β-sheet (1623 cm-1) gradually 
decrease with increasing temperature, and anti-parallel β-sheet intensity (1694 cm-1) gradually 
increase with increasing temperature. The relative intensity versus temperature for Aβ-
propofol complex in amide I region is shown in (Fig 4.18 B), while the relative intensity 
versus temperature in amide II region is shown in (Fig 4.19 B).  
The gradual decrease in parallel β-sheet intensity is believed to be mainly as a result of the 
unfolding of protein due to the formation of H-bonding between Aβ and propofol. The newly 
formed H-bonding will cause the C-N bond to assume a partial double bond character with 
C=O bond as a result of the electron flow from C=O to C-N, which will decrease the intensity 
of molecular vibration. The increase in anti-parallel β-sheet intensity with increasing 
temperature reflects more stability and low conversion of C=O bond of Aβ-propofol complex 
with increasing the temperature. (Lee 1986, Szabo et al.1999, Darwish et al. 2012) 
For Aβ-L-arginine spectra with increasing temperature, no appreciable peak shifts is observed 
in amide I region, while in amide II region the peak at 1567cm-1 has been shifted to 1561cm-1 
and the peak at 1551cm-1, which is believed to be due to disappearance of alpha-helix.   
A gradual decrease in anti-parallel β-sheet accompanied with an increase in parallel β-sheet 
intensity until the temperature reaches 33 C0 is noticed. Then anti-parallel β-sheet starts to 
82 
 
increase, and parallel β-sheet starts to decrease gradually. The same behavior is noticed in both 
amide I and amide II as shown in (Fig 4.18 C, and 4.19 C). 
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Figure 4.18: relative intensity versus temperature change in amide I band for A: Aβ-free 
(0.231mM), B: Aβ-propofol complex 0.48mM, and C: Aβ-L-arginine complex 0.48mM for 
bands at 1606, 1623, and 1694 cm-1. 
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Figure 4.19: relative intensity versus temperature change in amide II band for A: Aβ-free 
(0.231mM), B: Aβ-propofol complex 0.48mM, and C: Aβ-L-arginine complex 0.48mM for 
bands at 1489, 1528, and 1585 cm-1. 
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In the process of interpreting the effect of protein oligomerization memory function, one 
may assume that information and images are saved in the precursor proteins as oscillations 
with certain frequencies of formed bonds. Plaques formation and its effect on memory can 
be explained by assuming that propofol interaction with proteins in the brain produces a 
polarized dielectric material that is sandwiched between the unfolded β-sheet to create 
capacitor-like structure. The presence of this dielectric material will increase the internal 
energy of the arrangement leading to a more stable complex. The rigid structure is expected 
to prevent β-sheet from folding due to the additional constraints on its surface leading to 
plaques formations. The new solid structure causes the loss of the original frequency related 
to the saved information. L-arginine can be assumed to act as a dielectric material with low 
dielectric constant and this explains its different effect on Aβ. 
Radiation emitted and reflected from objects falls on human eye, this radiation is then 
turned to an oscillating signal of specific properties. This signal will pass through neurons 
searching for an identical signal saved in the brain. When the identical signal is found, brain 
tells what the object that has been seen is, and in this way memorizing occurs. When 
plaques formed they bind to neurons, this will cause bad transmission of signal. This will 
lead to memory loss accompanied with Alzheimer disease. 
 
4.4 Atomic force microscopy (AFM) 
 
AFM technique has been used as an additional method to investigate the effect of propofol and 
L-arginine on Aβ by taking images for Aβ solution, Aβ-propofol complex, and Aβ-L-arginine 
complex as shown in (Fig. 4.20) 
AFM images for Aβ-free, Aβ-propofol, and Aβ-L-arginine complexes are shown in (Fig 4.20 
A, 4.20 B, and 4.20 C respectively). The heights of species or clusters in each of these 
complexes when scanning the surface of the samples of Aβ-free, Aβ-propofol, and Aβ-L-
arginine are shown to the right of each image in the same figure (Fig 4.20). 
It has been found from AFM that Aβ species have clustered in a certain area as a result of 
interaction with propofol, this have not been noticed in the case of Aβ-L-arginine interaction. 
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From graph shown in (Fig. 4.20 A) the height of the clusters in Aβ-free sample was found to 
be between (30-35nm), while for Aβ-propofol sample it has been found to be (250-300nm) as 
shown in the graph in (Fig 4.20 B), for Aβ-L-arginine sample the height has been found to be 
(25-50). 
These results clearly indicate the effect of propofol in increasing the sizes of the clusters 
which are shown as spherical shaped objects. This confirms the results already found by FTIR 
spectroscopy that propofol enhances plaques formation. 
A little change in the heights of Aβ is noticed upon interaction with L-arginine as shown in 
(Fig. 4.20 A, and C). So L-arginine interacts with Aβ in a way different from that of propofol. 
These results confirm the results already found by FTIR spectroscopy. 
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Figure 4.20: AFM image of A: Aβ solution, B: Aβ-Propofol (0.96mM) complex, and C: Aβ-L-
arginine complex (0.96mM). The graph at the right to each image shows the changes in height 
at the surface of the sample responsible for that image. 
B 
A
C 
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Chapter Five 
 
 
Conclusions and future work 
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5.1 Conclusions 
 
In this research, the interaction of propofol and L-arginine with Aβ has been studied using 
UV-vis spectroscopy, fluorescence spectroscopy, FTIR spectroscopy, and AFM. The binding 
parameters for the binding of propofol and L-arginine with Aβ have been determined: For Aβ-
propofol and Aβ-L-arginine the binding constants are calculated by UV-vis spectroscopy to be 
K= 2.13ൈ 102M-1, and 0.35ൈ102M-1 respectively. The obtained values of the binding constants 
K by using fluorescence spectroscopy are 2.81ൈ102M-1, and 0.37ൈ102M-1 respectively. Which 
agree with the values obtained by UV-vis spectroscopy. In addition, the values of Stern-
Volmer quenching constants for both propofol and L-arginine are estimated to be (1.21ൈ103L 
mol-1 s-1, 1.49ൈ103L mol-1 s-1) respectively. 
These experimental results confirm the fact that dynamic quenching is not the main 
mechanism that causes the fluorescence quenching, and the decrease in fluorescence intensity 
occurred as a result of static quenching, which is indicative of a complex formation between 
the protein and the drug molecule. Also the low binding constant between the drug (propofol 
or L-arginine) and Aβ is due to the effective hydrogen bonding between these drugs and Aβ. 
Analysis of the FTIR spectra reveals that Aβ-propofol interaction has induced reduction in the 
absorption band of parallel β-sheet and random coils accompanied with an increase in anti-
parallel β-sheet and α-helix with different proportionality due to the different accessibility of 
H-bond formation in these components. This increase in the intensity of anti-parallel β-sheet 
with increasing propofol concentration is an indication that propofol increases the rate of 
oligomers or fibrils formation. On the other hand, analysis of the FTIR spectra for Aβ-arginine 
interaction reveals that a reduction in the intensity of the absorption band of anti-parallel β-
sheet and parallel β-sheet with increasing arginine concentration has occurred; also an increase 
in the intensity of random coil and α-helix is noticed. 
It is noticed that the behavior of L-arginine when interacting with Aβ is different than that of 
propofol; means that each one of them interact with Aβ in a different manner. Many studies 
have proven that amyloid oligomers or fibrils which are found in the brain of patients with 
Alzheimer disease are rich in β-sheet especially the more stable anti-parallel β-sheet. (Murphy 
2002, kirkitadze 2001, Lidgren 2010) Since increasing propofol concentration was shown to 
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increase the intensity of the absorption band of anti-parallel β-sheet, one can deduce that 
propofol increases the rate of oligomerization or fibrils formation. On the other hand arginine 
has the opposite effect as increasing its concentration decreases the intensity of anti-parallel β-
sheet. It can be concluded that arginine not only does not induce oligomerization, but it also 
may decrease the rates of oligomerization. 
Temperature study has shown that for Aβ-free no appreciable changes in the intensity of 
parallel and anti-parallel β-sheet with increasing temperature have noticed, while for Aβ-
propofol complex anti-parallel β-sheet intensity has increased gradually accompanied with a 
decrease in parallel β-sheet intensity. For Aβ-L-arginine complex, intensity of anti-parallel β-
sheet has decreased until temperature reached 330C then it started to increase, while parallel β-
sheet has increased until 330C, then it started to decrease. This have been found in both amide 
I and amide II regions.  
AFM images have been taken for Aβ free, Aβ-propofol complex, and Aβ-arginine complex. 
All these complexes have the same concentration of Aβ. A difference between these three 
images is noticed. These pictures confirm the formation of oligomers seen as clusters when 
propofol is added to Aβ, while the addition of L-arginine is shown to have different effect on 
Aβ oligomers formation. 
 
5.2 Future work 
 
The binding study of propofol and arginine with Aβ is of great importance in pharmacology 
and biochemistry. Our research can provide important information to medical and clinical 
researches about Alzheimer disease. It can provide theoretical basis for a new drug design. 
Further investigations are still needed to explain the role of anesthetics in initiating oligomers 
formation in proteins, and more clinical studies are needed to test these expectations. 
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ﻤﻊ ﺘﻁﺒﻴﻕ ﻋﺩﺩ ﻤﻥ ﺍﻟﺘﻘﻨﻴﺎﺕ ( RITF)ﺸﻌﺔ ﺘﺤﺕ ﺍﻟﺤﻤﺭﺍﺀ ﺒﺎﺴﺘﺨﺩﺍﻡ ﺠﻬﺎﺯ ﻤﻁﻴﺎﻑ ﺘﺤﻭﻴل ﻓﻭﺭﻴﻴﺭ ﻟﻸ
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ﻤﻴﺩ ﺍﻟﺜﺎﻨﻲ ﻤﻴﺩ ﺍﻻﻭل ﻭﺍﻷﺘﻡ ﺘﺤﻠﻴل ﻤﻨﻁﻘﺔ ﺍﻷ( gnittif evruc)ﻀﺎﻓﺔ ﺍﻟﻰ ﺘﻘﻨﻴﺔ ﺒﺎﻹ( noituloser
ﻭﺍﻟﻴﺔ ﺍﺭﺘﺒﺎﻁ ( erutcurts yradnoces)ﺠل ﺘﺤﺩﻴﺩ ﺒﻨﻴﺔ ﺍﻟﺒﺭﻭﺘﻴﻥ ﺍﻟﺜﺎﻨﻭﻴﺔ ﺃﻤﻴﻠﻭﻴﺩ ﻤﻥ ﺃﻟﺒﺭﻭﺘﻴﻥ ﺍﻟﺒﻴﺘﺎ 
ﻤﻴﺩ ﻕ ﺍﻷﻓﻲ ﻤﻨﺎﻁ( skaep)ﻜل ﻤﻥ ﺍﻟﺒﺭﻭﺒﻭﻓﻭل ﻭﺍﻷﺭﺠﻨﻴﻥ ﻤﻌﻪ ﺤﻴﺙ ﺘﻡ ﺘﺤﺩﻴﺩ ﺠﻤﻴﻊ ﻤﻭﺍﻗﻊ ﺍﻟﻘﻤﻡ 
ﺍﻟﺒﺭﻭﺒﻭﻓﻭل )ﺭ ﺍﻟﺘﻐﻴﺭﺍﺕ ﻓﻲ ﻤﻭﺍﻗﻊ ﺍﻟﻘﻤﻡ ﻨﺘﻴﺠﺔ ﺘﻐﻴﻴﺭ ﺘﺭﻜﻴﺯ ﺍﻷﺩﻭﻴﺔ ﺍﻟﻤﻀﺎﻓﺔ ﻴﺍﻻﻭل ﻭﺍﻟﺜﺎﻨﻲ ﻭﺘﻔﺴ
  (.ﻭﺍﻷﺭﺠﻨﻴﻥ
 noitprosbA)ﺍﻟﻰ ﺘﻐﻴﺭ ﻓﻲ ﺸﺩﺓ ﺤﺯﻡ ﺍﻻﻤﺘﺼﺎﺹ  )RITF(ﻴﺸﻴﺭ ﺍﻟﻁﻴﻑ ﺍﻟﻤﻘﺎﺱ ﺒﻭﺍﺴﻁﺔ ﺠﻬﺎﺯ 
ﺎﻓﺔ ﺍﻟﻰ ﺫﻟﻙ ﻅﻬﺭ ﻤﻥ ﺇﻀ(. ﺍﻟﺒﺭﻭﺒﻭﻓﻭل ﻭﺍﻷﺭﺠﻨﻴﻥ)ﻨﺘﻴﺠﺔ ﺘﻐﻴﺭ ﺘﺭﻜﻴﺯ ﺍﻷﺩﻭﻴﺔ ﺍﻟﻤﻀﺎﻓﺔ ( sdnab
ﺒﺯﻴﺎﺩﺓ ( teehs-β lellarap itna)ﺨﻼل ﺍﻟﻨﺘﺎﺌﺞ ﺃﻥ ﻫﻨﺎﻙ ﺯﻴﺎﺩﺓ ﻓﻲ ﺤﺯﻡ ﺍﻻﻤﺘﺼﺎﺹ ﺍﻟﺘﺎﺒﻌﺔ ﻟل
-β lellarap itna)ﺘﺭﻜﻴﺯ ﺍﻟﺒﺭﻭﺒﻭﻓﻭل ﻭﺒﺎﻟﻤﻘﺎﺒل ﻟﻭﺤﻅ ﻨﻘﺼﺎﻥ ﻓﻲ ﺤﺯﻡ ﺍﻻﻤﺘﺼﺎﺹ ﺍﻟﺘﺎﺒﻌﺔ ﻟل
  . ﺒﺯﻴﺎﺩﺓ ﺘﺭﻜﻴﺯ ﺍﻷﺭﺠﻨﻴﻥ( teehs
 - ﺍﻟﻨﺎﺘﺠﺔ ﻓﻲ ﺩﻤﺎﻍ ﺍﻟﻤﺼﺎﺒﻴﻥ ﺒﻤﺭﺽ ﺍﻟﺯﻫﺎﻴﻤﺭ( slirbif ro sremogilo diolymA)ﺘﻤﺘﺎﺯ ﺍﻟﺘﺭﺍﻜﻤﺎﺕ 
ﻭﺍﻟﺘﻲ ﺘﺭﺘﺒﻁ ﺒﺎﻟﻨﻬﺎﻴﺎﺕ ﺍﻟﻌﺼﺒﻴﺔ ﻓﺘﻌﻴﻕ ﺍﻨﺘﻘﺎل ﺍﻟﺴﻴﺎﻻﺕ ﺍﻟﻌﺼﺒﻴﺔ ﻤﻤﺎ ﻴﻨﺘﺞ ﻋﻨﻪ ﺍﻷﻋﺭﺍﺽ ﺍﻟﻤﺭﺍﻓﻘﺔ 
ﻓﻲ ﺒﻨﻴﺘﻪ ( teehs-β lellarap itna)ﺒﺯﻴﺎﺩﺓ ﻓﻲ  - ﻤﻥ ﻓﻘﺩﺍﻥ ﺍﻟﺫﺍﻜﺭﺓ ﻭﻏﻴﺭﻫﺎ ﻟﻤﺭﺽ ﺍﻟﺯﻫﺎﻴﻤﺭ
ﻭﺘﺄﺜﻴﺭ ﺍﻻﺭﺠﻨﻴﻥ ( sremogilo)ل ﻓﻲ ﺘﺤﻔﻴﺯ ﺘﻜﻭﻴﻥ ﺍﻟﺜﺎﻨﻭﻴﺔ ﻭﻫﺫﺍ ﻤﺅﺸﺭ ﻋﻠﻰ ﺘﺄﺜﻴﺭ ﺍﻟﺒﺭﻭﺒﻭﻓﻭ
   .ﺘﺄﺜﻴﺭ ﺍﻟﺒﺭﻭﺒﻭﻓﻭل ﺍﻟﻤﺨﺘﻠﻑ ﻋﻥ
ﻭﺠﺩ ﺃﻥ ﺍﻟﺒﺭﻭﺒﻭﻓﻭل ﻴﺯﻴﺩ ﻤﻥ ﺤﺠﻡ   )ypocsorciM ecroF cimotA( MFAﻭﻤﻥ ﺨﻼل ﺘﻘﻨﻴﺔ 
ﺍﻟﺘﺭﺍﻜﻤﺎﺕ ﺍﻟﻨﺎﺘﺠﺔ ﻓﻲ ﺍﻟﺒﻴﺘﺎ ﺃﻤﻴﻠﻭﻴﺩ ﻋﻨﺩ ﺍﻀﺎﻓﺘﻪ ﺍﻟﻴﻪ ﻜﻤﺎ ﻭﻟﻭﺤﻅ ﺃﻥ ﺘﺄﺜﻴﺭ ﺍﻻﺭﺠﻨﻴﻥ ﻜﺎﻥ ﻤﺨﺘﻠﻔﺎ ﺘﻤﺎﻤﺎ 
ﺍﻟﺯﻴﺎﺩﺓ ﻓﻲ ﺤﺠﻡ ﺍﻟﺘﺭﺍﻜﻤﺎﺕ ﺼﻐﻴﺭﺓ ﺠﺩﺍ ﻭﺒﺸﻜل ﻤﺨﺘﻠﻑ ﻋﻥ ﺍﻟﺘﺭﺍﻜﻤﺎﺕ ﺍﻟﻨﺎﺘﺠﺔ ﻋﻥ  ﺤﻴﺙ ﻜﺎﻨﺕ
  .ﺍﻟﺒﺭﻭﺒﻭﻓﻭل ﻭﻫﺫﺍ ﻴﺩﻋﻡ ﻤﺎ ﺘﻡ ﺍﻟﺘﻭﺼل ﺍﻟﻴﻪ ﺒﻁﺭﻕ ﺍﻟﺘﺤﻠﻴل ﺍﻷﺨﺭﻯ
